0001628280-23-013665 | 20-F | XBRL Viewer

Print Document View Excel Document

Cover	12 Months Ended
Cover	Dec. 31, 2022 shares
Document Information [Line Items]
Document Type	20-F
Document Registration Statement	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-41247
Entity Registrant Name	Satellogic Inc.
Entity Incorporation, State or Country Code	D8
Entity Address, Address Line One	Ruta 8 Km 17,500, Edificio 300Oficina 324 Zonamérica
Entity Address, City or Town	Montevideo,
Entity Address, Postal Zip Code	91600,
Entity Address, Country	UY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Accounting Standard	U.S. GAAP
Entity Shell Company	false
Entity Central Index Key	0001874315
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Auditor Firm ID	42
Class A ordinary shares
Document Information [Line Items]
Title of 12(b) Security	Class A Ordinary Shares
Trading Symbol	SATL
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding	75,612,795
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants
Trading Symbol	SATLW
Security Exchange Name	NASDAQ
Class B ordinary shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding	13,582,642
Business Contact
Document Information [Line Items]
Entity Address, Address Line One	210 Delburg Street
Entity Address, City or Town	Davidson
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28036
Contact Personnel Name	Rick Dunn
City Area Code	704
Local Phone Number	894-4482

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2022
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Location	Charlotte, North Carolina
Auditor Name	Ernst & Young LLP

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenue	$ 6,012,000	$ 4,247,000	$ 0
Costs and expenses
Cost of sales, exclusive of depreciation shown separately below	3,284,000	1,876,000	0
General and administrative expenses	37,191,000	36,640,000	8,003,000
Research and development	13,055,000	9,636,000	5,924,000
Depreciation expense	14,326,000	10,728,000	3,031,000
Other operating expenses	29,023,000	14,002,000	5,449,000
Total costs and expenses	96,879,000	72,882,000	22,407,000
Operating loss	(90,867,000)	(68,635,000)	(22,407,000)
Other income (expense), net
Finance costs, net	(652,000)	(9,738,000)	35,000
Change in fair value of financial instruments	58,311,000	17,983,000	9,637,000
Loss on extinguishment of debt	0	(37,216,000)	(9,240,000)
Other income, net	1,140,000	1,069,000	594,000
Total other income (expense), net	58,799,000	(27,902,000)	1,026,000
Loss before income tax	(32,068,000)	(96,537,000)	(21,381,000)
Income tax (expense) benefit	(4,573,000)	232,000	(148,000)
Net loss available to common stockholders	(36,641,000)	(96,305,000)	(21,529,000)
Other comprehensive loss
Foreign currency translation loss, net of tax	(226,000)	(86,000)	0
Comprehensive loss	$ (36,867,000)	$ (96,391,000)	$ (21,529,000)
Basic and diluted earnings per share
Basic loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.44)	$ (5.78)	$ (1.34)
Basic weighted-average common shares outstanding (in shares)	83,188,276	16,655,634	16,029,826
Diluted loss per share for the period attributable to common stockholders (in dollars per share)	$ (0.66)	$ (5.78)	$ (1.34)
Diluted weighted-average common shares outstanding (in shares)	83,798,149	16,655,634	16,029,826

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 76,528	$ 8,533
Restricted cash	126	0
Accounts receivable, net of allowance of $3,237 and $1,794, respectively	1,388	1,196
Prepaid expenses and other current assets	3,198	2,695
Total current assets	81,240	12,424
Property and equipment, net	47,981	32,530
Operating lease right-of-use assets	8,171	2,955
Deferred income tax assets	0	1,640
Other non-current assets	6,463	369
Total assets	143,855	49,918
Current liabilities
Accounts payable	9,850	6,650
Debt	0	108,473
Warrant liabilities	8,335	143,237
Earnout liabilities	1,353	0
Operating lease liabilities	2,176	985
Contract liabilities	1,941	935
Accrued expenses and other liabilities	6,417	23,435
Total current liabilities	30,072	283,715
Operating lease liabilities	6,063	2,083
Contract liabilities	1,000	1,000
Other non-current liabilities	522	2,552
Total liabilities	37,657	289,350
Commitments and contingencies (Note 20)
Redeemable preferred stock, $0.0001 par value	0	21,306
Stockholders' equity (deficit)
Preferred stock, $0.0001 par value	0	0
Common stock, $0.0001 par value	0	0
Treasury stock, at cost	(8,603)	(170,949)
Additional paid-in capital	337,928	96,471
Accumulated other comprehensive loss	(312)	(86)
Accumulated deficit	(222,815)	(186,174)
Total stockholders’ equity (deficit)	106,198	(260,738)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$ 143,855	$ 49,918
Redeemable preferred shares par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, par value (usd per share)	0.0001	0.0001
Par value (in dollars per share)	$ 0.0001	$ 0.0001

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 3,237	$ 1,794
Redeemable preferred shares par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, par value (usd per share)	0.0001	0.0001
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001

CONSOLIDATED STATEMENTS OF REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	Hannover	Cumulative Effect, Period of Adoption, Adjustment	Restricted stock units	Shares issued to Sponsor under Forward Purchase Securities Agreement	PIPE Warrant	Liberty Subscription Agreement	SPAC Public Warrants	Cantor Loan	Convertible Debt	Preferred stock	Preferred stock Hannover	Common stock	Common stock Hannover	Common stock Restricted stock units	Common stock Shares issued to Sponsor under Forward Purchase Securities Agreement	Common stock PIPE Warrant	Common stock Liberty Subscription Agreement	Common stock SPAC Public Warrants	Common stock Cantor Loan	Common stock Convertible Debt	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Additional paid-in capital Restricted stock units	Additional paid-in capital Shares issued to Sponsor under Forward Purchase Securities Agreement	Additional paid-in capital PIPE Warrant	Additional paid-in capital Liberty Subscription Agreement	Additional paid-in capital SPAC Public Warrants	Additional paid-in capital Cantor Loan	Additional paid-in capital Convertible Debt	Treasury stock	Accumulated other comprehensive loss	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019	0
Beginning balance at Dec. 31, 2019	$ 0
Ending balance (in shares) at Dec. 31, 2020	0
Ending balance at Dec. 31, 2020	$ 0
Beginning balance (in shares) at Dec. 31, 2019											8,740,398
Beginning balance (in shares) at Dec. 31, 2019													15,961,703
Beginning balance at Dec. 31, 2019	(5,449,000)		$ (1,384,000)																			$ 61,635,000	$ (123,000)								$ 0	$ 0	$ (67,084,000)	$ (1,261,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(21,529,000)																																(21,529,000)
Issuance of stock (in shares)													318,657
Issuance of stock	802,000																					802,000
Stock-based compensation	1,732,000																					1,727,000											5,000
Ending balance (in shares) at Dec. 31, 2020											8,740,398
Ending balance (in shares) at Dec. 31, 2020													16,280,360
Ending balance at Dec. 31, 2020	$ (25,828,000)																					64,041,000									0	0	(89,869,000)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Series X preferred stock (in shares)	2,033,230
Issuance of Redeemable Series X preferred stock	$ 20,332,000
Dividends on Redeemable Series X preferred stock	$ 974,000
Ending balance (in shares) at Dec. 31, 2021	2,033,230
Ending balance at Dec. 31, 2021	$ 21,306,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stockholder transaction & Hannover Holdings Transaction (in shares)											(4,128,413)
Preferred stockholder transaction & Hannover Holdings Transaction	(189,200,000)																					(18,251,000)									(170,949,000)
Extinguishment of Convertible Notes	39,009,000																					39,009,000
Exercise of stock options (in shares)													1,102,494
Exercise of stock options	791,000																					791,000
Net loss	(96,305,000)																																(96,305,000)
Comprehensive loss	(86,000)																															(86,000)
Stock-based compensation	$ 10,881,000																					10,881,000
Ending balance (in shares) at Dec. 31, 2021	4,611,985										4,611,985
Ending balance (in shares) at Dec. 31, 2021													17,382,854
Ending balance at Dec. 31, 2021	$ (260,738,000)																					96,471,000									(170,949,000)	(86,000)	(186,174,000)
Increase (Decrease) in Temporary Equity [Roll Forward]
Dividends on Redeemable Series X preferred stock	$ 97,000
Conversion of Series X preferred stock in connection with the reverse recapitalization (in shares)	(2,033,230)												(2,140,340)
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the reverse recapitalization	$ (21,403,000)																					(21,403,000)
Ending balance (in shares) at Dec. 31, 2022	0
Ending balance at Dec. 31, 2022	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Preferred stockholder transaction & Hannover Holdings Transaction (in shares)												(149,817)	(516,123)	(51,700)
Preferred stockholder transaction & Hannover Holdings Transaction	(2,750,000)	$ (5,853,000)																													(2,750,000)
Merger transaction and Reverse Recapitalization (in shares)											(4,462,168)
Merger transaction and Reverse Recapitalization	$ 5,145,000												$ 22,630,545									(165,804,000)									170,949,000
Stock issued during period, conversion of convertible securities (in shares)																	6,108,332	20,619,835	613,111	788,021	17,980,954
Stock issued during period, conversion of convertible securities					$ 10,000,000	$ 47,028,000	$ 120,506,000	$ 5,628,000	$ 7,880,000	$ 64,051,000															$ 10,000,000	$ 47,028,000	$ 120,506,000	$ 5,628,000	$ 7,880,000	$ 64,051,000
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)	2,033,230												2,140,340
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization	$ 21,403,000																					21,403,000
Reclassification of Columbia Warrant to equity	124,805,000																					124,805,000
Repayment of Columbia Loan	(3,418,000)																					(3,418,000)
Reclassification of Forfeiture Earnout Liability to equity	$ 1,005,000																					1,005,000
Exercise of stock options (in shares)	102,825														223,218
Exercise of stock options				$ 144,000																				$ 144,000
Net loss	$ (36,641,000)																																(36,641,000)
Comprehensive loss	(226,000)																															(226,000)
Issuance of stock (in shares)																				26,050
Issuance of stock									$ 167,000																				$ 167,000
Withholding of stock units to satisfy tax withholding obligations upon the vesting of restricted stock units and exercise of stock options				$ (306,000)																				$ (306,000)
Stock-based compensation	8,368,000																					8,368,000
Ending balance (in shares) at Dec. 31, 2022											0
Ending balance (in shares) at Dec. 31, 2022													89,195,437
Ending balance at Dec. 31, 2022	$ 106,198,000																					$ 337,928,000									$ (8,603,000)	$ (312,000)	$ (222,815,000)
Beginning balance (in shares) at Jan. 24, 2022	17,215,336
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued during period, conversion of convertible securities (in shares)																1,250,000
Issuance of stock (in shares)					1,250,000
Ending balance (in shares) at Jan. 25, 2022	88,824,647

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (36,641)	$ (96,305)	$ (21,529)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	14,326	10,728	3,031
Operating lease expense	2,015	548	298
Deferred tax expense (benefit)	1,601	(1,619)	(38)
Stock-based compensation	8,368	10,881	1,732
Interest expense	1,693	9,703	43
Change in fair value of financial instruments	(58,311)	(17,983)	(9,637)
Loss on debt extinguishment	0	37,216	9,240
Expenses related to Merger	9,859	0	0
Foreign exchange differences	(4,578)	(2,385)	(1,507)
Loss on disposal of property and equipment and right of use assets	996	579	372
Bad debt expense	1,736	1,794	0
Changes in operating assets and liabilities:
Accounts receivable	(1,928)	(4,691)	(221)
Prepaid expenses and other current assets	(1,855)	21	(14)
Accounts payable	(3,202)	1,421	6,474
Contract liabilities	1,006	480	455
Accrued expenses and other liabilities	(1,562)	21,622	497
Operating lease liabilities	(1,985)	(449)	(370)
Net cash used in operating activities	(68,462)	(28,439)	(11,174)
Cash flows from investing activities:
Acquisitions of property and equipment	(27,252)	(11,233)	(15,787)
Equity investment in OS	(3,653)	0	0
Other	53	3	14
Net cash used in investing activities	(30,852)	(11,230)	(15,773)
Cash flows from financing activities:
Proceeds from issuance of redeemable Series X preferred stock	0	20,332	0
Proceeds from issuance of debt	0	7,513	17,348
Repurchase of stock	(8,603)	0	0
Proceeds from exercise of Public Warrants	5,291	0	0
Proceeds from sale of common stock	167,504	0	0
Proceeds from exercise of stock options	144	791	802
Net cash provided by financing activities	164,336	28,636	18,150
Net increase in cash, cash equivalents and restricted cash	65,022	(11,033)	(8,797)
Effect of foreign exchange rate changes	4,237	2,299	1,507
Cash, cash equivalents and restricted cash - beginning of period	8,533	17,267	24,557
Cash, cash equivalents and restricted cash - end of period	$ 77,792	$ 8,533	$ 17,267

Nature of the Business and Basis of Presentation	12 Months Ended
Nature of the Business and Basis of Presentation	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of the Business and Basis of Presentation	Nature of the Business and Basis of Presentation Nature of the Business On January 25, 2022 (the “Closing Date”), Satellogic Inc. (“Satellogic” or the “Company”), a BVI business company incorporated in the BVI as a company limited by shares, consummated the transactions contemplated by the Agreement and Plan of Merger dated as of July 5, 2021 (the “Merger Agreement”), by and among the Company, CF Acquisition Corp. V, a Delaware corporation (“CF V” and now known as “Satellogic V Inc.”), Ganymede Merger Sub 1 Inc., a BVI business company incorporated in the BVI as a company limited by shares and a direct wholly owned subsidiary of the Company, Ganymede Merger Sub 2 Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company, and Nettar. Nettar was, prior to the transaction, the holding company of the Satellogic group and was incorporated on October 7, 2014, under the laws of the BVI as a company limited by shares. The registered office of Satellogic is located at Kingston Chambers BOX 173 C/O Maples Corporate Services BVI LTD Road Town, Tortola D8 VG1110. References to “Nettar” contained herein refer to Nettar Group Inc. prior to the mergers, and references to “the Company,” “we,” “our,” “us” or “Satellogic” refer to Satellogic Inc. prior to the mergers and to the combined company following the mergers. Through our subsidiaries, we invest in the software, hardware, and optics of the aerospace industry focusing on satellite and image analytics technologies. Our strategy is to build a planetary scale analytics platform based on a proprietary satellite constellation with the capability to generate insights from images and information, with focus on multi-temporal analysis and high frequency of revisits. We also intend to leverage our ability to quickly build and launch high quality, sub-meter satellites at a low cost by selling satellites to certain key customers. Basis of Presentation The accompanying Consolidated Financial Statements as of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020 (“the Consolidated Financial Statements”) have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The Company conducts business through one operating segment. The accompanying Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions, including the intercompany portion of transactions with equity method investees, have been eliminated in consolidation. The Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”). Historically the consolidated financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board. For the Consolidated Financial Statements, we have prepared our consolidated financial statements in accordance with U.S. GAAP. The change from reporting in IFRS to U.S. GAAP was treated as a change in accounting standard, whereby we retrospectively applied the change to all prior reporting periods contained in these Consolidated Financial Statements. Where the initial adoption of U.S. GAAP resulted in a material change in an asset or liability, the adjustment was reported to the opening balance of accumulated deficit and additional paid-in capital as of January 1, 2020. Refer to Note 19 (Adoption of U.S. GAAP) for additional information. Certain prior year amounts have been reclassified to conform to the current year presentation. Emerging Growth Company We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (“the Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). The JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised that has different application dates for public or private companies, we can adopt the new or revised standard at the time required for private companies to adopt such standard. The foregoing may make comparison of our financial statements with those of another public company difficult or impossible if such other public company is (i) not an emerging growth company or (ii) is an emerging growth company that has opted out of using the extended transition period, due to the potential differences in accounting standards used. Liquidity Since our formation, we have devoted substantial effort and capital resources to the development of our satellite constellation and image technologies. As of December 31, 2022, we had an accumulated deficit of $222.8 million. For the year ended December 31, 2022, we had net cash used in operating activities of $68.5 million. As of December 31, 2022, we had cash and cash equivalents of $76.5 million. We anticipate losses and negative operating cash flows to continue, primarily as a result of our satellite constellation expansion as we obtain adequate sources of funding through revenue growth. We believe we will have sufficient funding for at least the next 12 months from the date these Consolidated Financial Statements are issued. Failure to generate revenue growth with sufficient positive cash flows from operations or to raise additional funding in the longer term may require us to alter, or scale back, our capital expenditures and could have a material adverse effect on our ability to achieve its intended business objectives.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Use of Estimates

The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Consolidated Financial Statements include, but are not limited to, revenue recognition; determination of useful lives of property and equipment; valuation of warrant liabilities, earnout liabilities, stock options; and determination of income tax. We evaluate our estimates and assumptions on an ongoing basis. Actual results could differ from those estimates and such differences may be material to the Consolidated Financial Statements.

Revenue Recognition

We recognize revenue in accordance with Topic 606 Revenue from contracts with customers. Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for goods or services provided under such contracts. We apply the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) we satisfy each performance obligation.

Our main revenue stream is from services. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our satellite imagery can be delivered to customers in two ways, either by providing access via our platform or via electronic delivery.

The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered.

We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third parties, weather conditions), (ii) uncertainty about the amount of consideration is not expected to be resolved for a long period of time, (iii) our experience with similar types of contracts is limited, or that experience has limited predictive value, (iv) we have a practice of either offering a broad range of price concessions or changing the payment terms and conditions of similar contracts in similar circumstances, and (v) the contract has a large number and broad range of possible consideration amounts.

We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price.

Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services.

We generally do not enter into long-term financing arrangements or payment plans with customers. Although our business practice is not to enter into contracts with non-cash consideration, at times this may occur. In these instances, we determine the fair value of the non-cash consideration at contract inception and includes this value as part of the total arrangement consideration. In instances where we cannot reasonably estimate the fair value of the non-cash consideration, we will measure the consideration indirectly by reference to its stand-alone selling price of the goods promised to the customer in exchange for consideration.

Fair Value Measurement

Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP.

Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Financial instruments carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:

•Level 1: Quoted prices in active markets for identical assets or liabilities.

•Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.

•Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

Assets and liabilities recognized at fair value on a recurring basis in the Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy.

For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.

Credit risk management

Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables.

The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk.

The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions.

As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 to 90 days.

Impairment of Assets

We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. An impairment is considered to exist if the total estimated future cash flows on an undiscounted basis are less than the carrying amount of the assets or asset group. We performed an impairment test as of December 31, 2022, 2021 and 2020 due to our net loss for those years and concluded that the asset group is not impaired.

Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition.

If estimates or underlying assumptions change in the future, we may be required to record impairment charges. If the fair value of an asset group is less than its carrying amount, then the carrying amount of the asset group would be reduced to its fair value. That reduction is an impairment loss that would be recognized in the Consolidated Statements of Operations and Comprehensive Loss.

Equity Method Investments

We account for equity investments in which we have significant influence, but not a controlling financial interest, using the equity method of accounting. Under the equity method of accounting, investments are initially recorded at cost, less impairment, and subsequently adjusted to recognize our share of earnings or losses as a component of Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. Our equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in value. We have not recorded any impairment losses related to our equity method investments during the year ended December 31, 2022. We did not hold any equity investments in 2021 or 2020.

Stock-Based Compensation

We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience.

The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs:

Expected term - The simplified method is used to calculate the expected term.

Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries.

Expected dividend yield - We do not use a dividend rate due to the fact that we have never declared or paid cash dividends on the Company’s common stock and we do not anticipate doing so in the foreseeable future.

Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.

The fair values for restricted stock units ("RSUs") with service-based vesting conditions are calculated based upon our closing stock price on the date of the grant.

Foreign Currencies

The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss.

Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, and 2020, respectively.

Leases

We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not provide an implicit rate. For real estate and equipment contracts, we generally account for the lease and non-lease components as a single lease component. In assessing the lease term, we include options to renew only when we are reasonably certain that such option(s) will be exercised; a determination which is at our sole discretion. Variable lease payments are recognized as expenses in the period incurred. For leases with an initial term of 12 months or less, we have elected to not record an ROU asset and lease liability. We record lease expense on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets, beginning on the commencement date.

We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not accounted for as a separate contract. The lease liability is remeasured when there is a change in the lease term or in the assessment of whether we will exercise a lease option. We assess ROU assets for impairment in accordance with our long-lived asset impairment policy.

We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not based on an observable index and lease agreements with an original duration of less than 12 months are recorded directly to lease expense.

For the periods presented, we do not have any financing type leases.

Accounts Receivable and Allowance for Doubtful Accounts

Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts, discounts, returns and rebates. We measure the allowance for doubtful accounts based on the estimated loss.

In calculating an allowance for doubtful accounts, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics which have been grouped based on the days past due.

Accounts are written off against the allowance account when they are determined to be no longer collectible. The following table shows the activity in the allowance for doubtful accounts for the years ended December 31, 2022 and 2021:


	December 31,
	2022		2021
Allowance for doubtful accounts as of beginning of period	$	1,794	$	—
Provision	1,736		1,794
Write-offs	—		—
Foreign exchange and other	(293)		—
Allowance for doubtful accounts as of end of period	$	3,237	$	1,794

Cash, Cash Equivalents and Restricted Cash

Cash and cash equivalents include deposits in banks and short-term (original maturities of three months or less at the time of purchase), highly liquid investments that are readily convertible to known amounts of cash with a maturity of three months or less at the time of purchase.

Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.


	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash	126		—
Restricted cash included in Other non-current assets	1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Cash Flow Information


	Year Ended December 31,
	2022		2021		2020
Cash paid during the period for:
Income tax, net of refunds	$	758	$	96	$	59
Interest	$	3,520	$	49,283	$	27,286

Accounting Standards Updates (“ASU”)

12 Months Ended

Dec. 31, 2022

Accounting Standards Update and Change in Accounting Principle [Abstract]

Accounting Standards Updates (“ASU”)

Accounting Standards Recently Adopted

In May 2021, the FASB issued ASU 2021-04, Earnings per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), which clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified upon modification or exchange. This ASU is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity applies the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements.

In January 2020, the FASB issued ASU 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of accounting for equity securities, investments accounted for under the equity method of accounting, and the accounting for certain forward contracts and purchase options, under the aforementioned topics. This ASU is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity applies the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) which is part of the FASB’s overall simplification initiative to reduce the costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. ASU 2019-12 simplifies accounting guidance for intra-period allocations, deferred tax liabilities, year-to-date losses in interim periods, franchise taxes, step-up in tax basis of goodwill, separate entity financial statements, and interim recognition of tax laws or rate changes. ASU 2019-12 is effective for emerging growth companies following private company adoption dates in fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements.

Accounting Standards Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade receivables, resulting in an earlier recognition of losses than under the current incurred loss approach, which requires waiting to recognize a loss until it is probable of being incurred. This standard is effective for us beginning January 1, 2023 and will be adopted using the modified retrospective transition method through a cumulative-effect adjustment to retained earnings as of the effective date. Upon adoption, the standard is expected to only impact our account for credit losses related to accounts receivable. In preparation for the adoption of the new standard, we have updated certain policies and related processes, but we do not expect the adoption of this new guidance will have a material impact on the Consolidated Financial Statements.

Adoption of U.S. GAAP

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2021:


	Year Ended December 31, 2021
	IFRS		Adjustments/ Reclassifications		Note	U.S. GAAP
Revenue	$	4,247	$	—		$	4,247
Costs and expenses
Cost of sales	1,876		—			1,876
General administrative expenses	36,649		(9)		a, c	36,640
Research and development	9,640		(4)		b	9,636
Depreciation expense	10,825		(97)		b	10,728
Other operating expenses, net	14,002		—			14,002
Total costs and expenses	72,992		(110)			72,882
Operating loss	(68,745)		110			(68,635)
Other income (expense), net
Finance costs, net	(11,769)		2,031		c, d	(9,738)
Change in fair value of financial instruments	(42,102)		60,085		d	17,983
Gain (loss) on extinguishment of debt	3,576		(40,792)		d	(37,216)
Other income (expense), net	1,067		2		c	1,069
Total other income (expense), net	(49,228)		21,326			(27,902)
Loss before income tax	(117,973)		21,436			(96,537)
Income tax	232		—			232
Net loss available to common stockholders	$	(117,741)	$	21,436		$	(96,305)
Other comprehensive loss
Foreign currency translation loss, net of tax	(86)		—			(86)
Comprehensive loss	$	(117,827)	$	21,436		$	(96,391)

Basic loss for the period attributable to common stockholders	$	(7.07)	$	1.29	e	$	(5.78)
Basic weighted-average common shares outstanding	16,655,634		—		e	16,655,634
Diluted loss for the period attributable to common stockholders	$	(7.07)	$	1.29	e	$	(5.78)
Diluted weighted-average common shares outstanding	16,655,634		—		e	16,655,634

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2020:


	Year Ended December 31, 2020
	IFRS		Adjustments/ Reclassifications		Note	U.S. GAAP
Revenue	$	—	$	—		$	—
Costs and expenses
Cost of sales	—		—			—
General administrative expenses	8,127		(124)		a, c	8,003
Research and development	5,878		46		a, b	5,924
Depreciation expense	3,182		(151)		b	3,031
Other operating expenses, net	5,476		(27)		a, b	5,449
Total costs and expenses	22,663		(256)			22,407
Operating loss	(22,663)		256			(22,407)
Other income (expense), net
Finance costs, net	(22)		57		c, d	35
Change in fair value of financial instruments	(84,224)		93,861		d	9,637
Gain (loss) on extinguishment of debt	(7,466)		(1,774)		d	(9,240)
Other income (expense), net	597		(3)		c	594
Total other income (expense), net	(91,115)		92,141			1,026
Loss before income tax	(113,778)		92,397			(21,381)
Income tax	(148)		—			(148)
Net loss available to common stockholders	$	(113,926)	$	92,397		$	(21,529)
Other comprehensive loss
Foreign currency translation loss, net of tax	—		—			—
Comprehensive loss	$	(113,926)	$	92,397		$	(21,529)

Basic loss for the period attributable to common stockholders	$	(7.11)	$	5.76	e	$	(1.34)
Basic weighted-average common shares outstanding	16,029,826		—		e	16,029,826
Diluted loss for the period attributable to common stockholders	$	(7.11)	$	5.76	e	$	(1.34)
Diluted weighted-average common shares outstanding	16,029,826		—		e	16,029,826

Reconciliation of the Consolidated Balance Sheet as of December 31, 2021:


	IFRS		Adjustments / Reclassifications		Note	U.S. GAAP
ASSETS
Current assets
Cash and cash equivalents	$	8,533	$	—		$	8,533
Accounts receivable	1,196		—			1,196
Prepaid expenses and other current assets	2,695		—			2,695
Total current assets	12,424		—			12,424
Property and equipment, net	33,586		(1,056)		b	32,530
Operating lease right-of-use assets	2,663		292		c	2,955
Deferred income tax assets	1,640		—			1,640
Other non-current assets	369		—			369
Total assets	$	50,682	$	(764)		$	49,918
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	6,650	$	—		$	6,650
Debt	246,189		(137,716)		d	108,473
Warrant liabilities	—		143,237		d	143,237
Operating lease liabilities	891		94		c	985
Contract liabilities	935		—			935
Accrued expenses and other liabilities	23,435		—			23,435
Total current liabilities	278,100		5,615			283,715
Operating lease liabilities	1,908		175		c	2,083
Contract liabilities	1,000		—			1,000
Other non-current liabilities	2,552		—			2,552
Total liabilities	283,560		5,790			289,350
Redeemable preferred stock	—		21,306		d	21,306
Stockholders' equity (deficit)
Treasury stock	(170,949)		—			(170,949)
Additional paid-in capital	235,909		(139,438)		a, d	96,471
Accumulated other comprehensive loss	(86)		—			(86)
Accumulated deficit	(297,752)		111,578			(186,174)
Total stockholders’ equity (deficit)	(232,878)		(27,860)			(260,738)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	50,682	$	(764)		$	49,918

a.Stock-based compensation

Certain awards granted by us have a service inception date preceding the grant date. Under IFRS, this resulted in the recognition of stock-based compensation expense prior to the grant date. Under U.S. GAAP, the stock-based compensation expense shall not be recognized until authorization at the grant date.

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
General and administrative expenses	$	(80)	$	(136)
Research and development	—		(89)
Other operating expenses	—		(27)
Increase (decrease) to loss before income tax	$	(80)	$	(252)


(Consolidated Balance Sheet)	December 31, 2021
Additional paid-in-capital	$	542
Adjustment to accumulated deficit	(542)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	—

b.Research and development

Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
Research and development	$	(4)	$	135
Depreciation expense	(97)		(151)
Other operating expenses	—		—
Increase (decrease) to loss before income tax	$	(101)	$	(16)


(Consolidated Balance Sheet)	December 31, 2021
Property and equipment, net	$	(1,056)
Total assets	$	(1,056)
Adjustment to accumulated deficit	$	(1,056)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	(1,056)

c.Leases

Under IFRS, all recognized leases are accounted for similarly to finance leases. Under U.S. GAAP, there is a dual classification on-balance sheet lease accounting model for lessees: finance and operating leases. Operating leases create a straight-line expense, and no interest expense is recognized on the lease liability.

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
General and administrative expenses	$	71	$	12
Less: Finance costs, net	(49)		(57)
Less: Other income, net	(2)		3
Increase (decrease) to loss before income tax	$	20	$	(42)


(Consolidated Balance Sheet)	December 31, 2021
Operating lease right-of-use assets	$	292
Total assets	$	292
Operating lease liabilities	$	94
Non-current operating lease liabilities	175
Adjustment to accumulated deficit	23
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	292

d.Financial instruments

Under IFRS, the redeemable Series X preferred shares and convertible notes contained conversion features that resulted in a bifurcated derivative component with changes in fair value recognized as gain or (loss). Under U.S. GAAP, the conversion features did not result in a material bifurcated embedded derivative, resulting in the elimination of the change in fair value of financial instruments, reduction in interest expense and preferred dividends expense, and increase in the gain (loss) on extinguishment of debt.

Under IFRS, it was determined that the redeemable Series X preferred shares should be classified as a liability since there is a contractual obligation to deliver cash or another financial asset and certain conversion events being beyond our control. Under U.S. GAAP, it was determined that the redeemable Series X preferred shares should be classified as mezzanine equity since the shares are redeemable based on events outside of our control.

Under IFRS, it was determined that the Columbia Warrant should be classified as equity since settlement would only occur by exchanging a fixed amount of cash for a fixed number of our own equity instruments. Changes in fair value are not recognized. Under U.S. GAAP, it was determined that the Columbia Warrant should be classified as a liability since the number and type of shares received could be different pre- and post- Merger. The Columbia Warrant is recorded at fair value with changes recognized in the Consolidated Statement of Operations and Comprehensive Loss.

Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statements of Operations and Comprehensive Loss)	2021		2020
Less: Finance costs, net	$	(1,982)	$	—
Less: Change in fair value of financial instruments	(60,085)		(93,861)
Less: Gain (Loss) on extinguishment of debt	40,792		1,774
Increase (decrease) to loss before income tax	$	(21,275)	$	(92,087)


(Consolidated Balance Sheet)	December 31, 2021
Debt	$	(137,716)
Redeemable Series X preferred stock	21,306
Warrant liability	143,237
Additional paid-in capital	(139,980)
Adjustment to accumulated deficit	113,153
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	—

e.Net loss per share

The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:


	Year Ended December 31,
	2021		2020
Net loss attributable to common stockholders	$	(96,305)	$	(21,529)
Basic weighted-average common shares outstanding (1)	16,655,634		16,029,826
Basic loss per share for the period attributable to common stockholders	$	(5.78)	$	(1.34)

Dilutive numerator	$	(96,305)	$	(21,529)
Diluted weighted-average common shares outstanding	16,655,634		16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(5.78)	$	(1.34)

(1) After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

- Definition

The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-URI https://asc.fasb.org/topic&trid=2122394

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 105
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (d)(1)
-URI https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iii)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(ii)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(i)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (d)(2)
-URI https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (g)(2)(iv)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section S99
-Paragraph 5
-Subparagraph (SAB Topic 11.M.Q2)
-URI https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (e)(1)
-URI https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (h)(2)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (e)(2)
-URI https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 848
-SubTopic 10
-Section 65
-Paragraph 1
-Subparagraph (e)(1)
-URI https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (e)(2)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section S99
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=122038215&loc=SL108384541-122693

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 10
-Section 65
-Paragraph 5
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (e)(2)
-URI https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (c)(2)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 10
-Section 65
-Paragraph 5
-Subparagraph (f)(3)
-URI https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (e)(1)
-URI https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (e)(1)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (c)(3)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 65
-Paragraph 2
-Subparagraph (f)(3)
-URI https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (e)(3)
-URI https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 848
-SubTopic 10
-Section 65
-Paragraph 2
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (e)(3)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

+ Details

Reverse Recapitalization

12 Months Ended

Dec. 31, 2022

Reverse Recapitalization [Abstract]

Reverse Recapitalization

On January 25, 2022, and pursuant to the Merger Agreement, the merger between the Company and CF V (the “Merger”) was accounted for as a reverse recapitalization (the “Reverse Recapitalization”) in accordance with U.S. GAAP. Under this method of accounting, CF V was treated as the “acquired” company and Satellogic was treated as the acquirer for financial reporting purposes. Accordingly, for accounting purposes, the reverse recapitalization was treated as the equivalent of the Company issuing stock for the net assets of CF V, accompanied by a recapitalization. The net assets of CF V were stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the Merger represent those of the Company.

The transaction resulted in net cash proceeds of $168 million, after transaction expenses and debt repayment, through the contribution of cash held in CF V’s trust account, net of redemptions by CF V’s public stockholders, and a concurrent private placement offering led by SoftBank’s SBLA Advisers Corp. and Cantor Fitzgerald & Co. (“CF&Co.”), among other institutional investors, and the Liberty Investment, as defined and described further below.

On the Closing Date, the Company consummated the Merger contemplated by the Merger Agreement, including the following:

Private Placement (“PIPE”) Investment

Pursuant to the relevant subscription agreement, Satellogic issued 5,816,770 Class A ordinary shares and a non-redeemable warrant (“PIPE Warrant”) to purchase 2,500,000 Class A ordinary shares to a PIPE investor at an exercise price of $20.00 per share, for an aggregate purchase price of $58.2 million.

Forward Purchase Agreement

In July 2021, CFAC Holdings V, LLC (the “Sponsor”), CF V, and Satellogic entered into the Amended and Restated Forward Purchase Agreement (“FPA”), pursuant to which Satellogic issued to the Sponsor 1,250,000 Class A ordinary shares, and warrants to purchase an additional 333,333 Class A ordinary shares at an exercise price of $11.50 per share (“Forward Purchase Warrant”), for an aggregate purchase price of $10.0 million.

Cantor Loan

Satellogic and Cantor Fitzgerald Securities (“CF Securities”) entered into a Secured Promissory Note, dated December 23, 2021 (the “Promissory Note”), pursuant to which CF Securities agreed to loan $7.5 million to Satellogic (the “Cantor Loan”). On January 18, 2022, CF Securities, Satellogic and Nettar entered into the Promissory Note Waiver Letter (the “Promissory Note Waiver Letter”) pursuant to which Satellogic and CF Securities agreed that the Company would repay the Cantor Loan, including all principal and interest by the issuance of 788,021 Class A ordinary shares. Such repayment occurred on the Closing Date.

Redeemable Series X Preferred Stock

Per the transaction, the 2,033,230 outstanding shares of redeemable Series X preferred stock and accrued dividends in the amount of $21.4 million were converted to 2,140,340 Class A ordinary shares.

Liberty Investment

On January 18, 2022, Satellogic and CF V entered into the Liberty Subscription Agreement with an investor (the “Liberty Investor”). Satellogic agreed to issue and sell to the Liberty Investor (i) 20,000,000 of Satellogic’s Class A ordinary shares (the “Liberty Shares”), (ii) a warrant to purchase up to 5,000,000 Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “$10.00 Liberty Warrant”), and (iii) a warrant to purchase up to 15,000,000 of Satellogic’s Class A ordinary shares at an exercise price of $15.00 per share (the “$15.00 Liberty Warrant”, and together with the $10.00 Liberty Warrant, the “Liberty Warrants”), in a private placement for an aggregate purchase price of $150.0 million. The transaction closed on February 10, 2022 (the “Liberty Closing” and the transaction collectively, the “Liberty Investment”).

An advisory fee is payable by Satellogic in exchange for advisory services to be provided to Satellogic from time to time until a Cessation Event (as defined in the Liberty Subscription Agreement). The advisory fee includes a warrant to purchase 2,500,000 of Satellogic’s Class A ordinary shares at an exercise price of $10.00 per share (the “Liberty Advisory Fee Warrant”), which was issued at the Liberty Closing, and for so long as a Cessation Event has not occurred, $1.25 million to be paid in cash on the 18-month anniversary of the Liberty Closing and on the last day (or, if not a business day, the immediately following business day) of each of the following five successive three-month anniversaries of such 18-month anniversary (each, an “Advisory Fee Cash Payment” and together, the “Advisory Fee Cash Payments”), representing an aggregate of up to $7.5 million in Advisory Fee Cash Payments.

The Liberty Advisory Fee Warrant became exercisable as of and from February 10, 2023, and will expire on the fifth anniversary of the Liberty Closing (i.e., February 10, 2027). The Liberty Advisory Fee Warrant is subject to substantially the same terms as the Liberty Warrants.

Transaction Fees

On January 18, 2022, CF V, Satellogic and CF&Co. entered into the CF Fee Letter, pursuant to which Satellogic agreed to pay cash of $5.0 million and issue an aggregate of 2,058,229 of Satellogic’s Class A ordinary shares in payment of certain Merger-related transaction fees. Such payments were made on the Closing Date.

Company Stockholders

In connection with the Merger Transaction:

•the common stock and preferred stock of Nettar that were issued and outstanding immediately prior to the Merger were automatically canceled and ceased to exist in exchange for Satellogic’s Class A ordinary shares, as determined in accordance with the Merger Agreement;

•all Convertible Notes of Nettar converted into Nettar Preferred Shares which were exchanged for shares of Satellogic’s Class A ordinary shares as determined in the Merger Agreement;

•all options to purchase common stock of Nettar were assumed by the Company and became options to purchase Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement;

•the Columbia Warrant (as defined below) outstanding immediately prior to the Merger became exercisable for that number of Satellogic’s Class A ordinary shares as determined in accordance with the Merger Agreement.

The following table illustrates the shares issued to our stockholders after giving effect to the 3.3028 Exchange Ratio in accordance with the transactions contemplated by the Merger Agreement as of the Closing Date and the issuance of shares pursuant to the transactions described above:


Company stockholders			Shares
Class A stockholders immediately prior to merger			17,215,336
Series A preferred stockholders			7,968,316
Series B preferred stockholders			4,597,928
Series B-1 preferred stockholders			2,171,399
2018 convertible noteholders			5,581,416
2019 convertible noteholders			7,846,333
2020 convertible noteholders			4,553,205
Redeemable Series X preferred stockholders			2,140,340
Liberty investors			20,000,000
PIPE investors			5,816,770
Shares issued for Cantor loan repayment			788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement			1,250,000
Issuance of shares for transaction fees			2,058,229
CF V shares			6,837,354
			88,824,647

Revenue from Contract with Customers

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenue from Contract with Customers

Revenue from Contracts with CustomersDuring the year ended December 31, 2022, we recognized revenue of $6.0 million, of which $1.6 million was recognized over time and $4.4 million was recognized at a point-in-time. During the year ended December 31, 2021, we recognized revenue of $4.2 million, of which $3.8 million was recognized over time and $0.4 million was recognized at a point-in-time. We did not recognize any revenue in 2020.

Information about our revenue by geography is as follows:


	Year Ended December 31,
	2022		2021
Revenue by geography (1)
Asia Pacific	$	1,531	$	3,988
North America	3,438		201
Other	1,043		58
Total revenue	$	6,012	$	4,247

(1)Revenue by geography is based on the geographical location of the customer.

Two customers each accounted for more than 10% of our revenue totaling $4.8 million for the year ended December 31, 2022. One customer accounted for more than 10% of our revenue totaling $3.9 million for the year ended December 31, 2021.

Contract Liabilities and Remaining Performance Obligations

Our contract liabilities consist of payments received from customers, or such consideration contractually due, in advance of providing the relevant satellite imagery or related service. Amounts included in Contract liabilities are as follows:


	December 31,
	2022		2021
Non-current	$	1,000	$	1,000
Current	1,941		935
Total	$	2,941	$	1,935

During the year ended December 31, 2022, we recognized revenue of $0.9 million that was included as a Contract liability as of December 31, 2021. During the year ended December 31, 2021, we recognized revenue of $0.5 million that was included as a Contract liability as of December 31, 2020.

A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. The following table represents the total transaction price for the remaining performance obligations as of December 31, 2022 related to non-cancellable contracts longer than 12 months in duration that is expected to be recognized over future periods.


	Within 1 Year		Years 1-2		Years 2-3		Thereafter
Remaining performance obligations	$	6,422	$	11,296	$	3,860	$	—

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

Warrant Liabilities

12 Months Ended

Dec. 31, 2022

Other Liabilities Disclosure [Abstract]

Warrant Liabilities


	Liberty Warrants and Liberty Advisory Fee Warrant		PIPE Warrant		Columbia Warrant		$8.63 Warrants		Total Warrant Liabilities
As of December 31, 2021	$	—	$	—	$	143,237	$	—	$	143,237
Warrants issued	$	30,853	$	1,312	$	—	$	4,872	$	37,037
Change in fair value of financial instruments	(24,662)		(1,001)		(18,635)		(2,702)		(47,000)
Write-off of deferred costs	—		—		203		—		203
Settlements	—		—		—		(337)		(337)
Reclassification to equity	—		—		(124,805)		—		(124,805)
As of December 31, 2022	$	6,191	$	311	$	—	$	1,833	$	8,335

Liberty Warrants and Liberty Advisory Fee Warrant

The Liberty Warrants and the Liberty Advisory Fee Warrant were initially recognized as a liability with a fair value of $30.9 million. The Liberty Warrants and the Liberty Advisory Fee Warrant remain unexercised and were remeasured to fair value of $6.2 million as of December 31, 2022.

PIPE Warrant

The PIPE Warrant was initially recognized as a liability with a fair value of $1.3 million. The PIPE Warrant remains unexercised and was remeasured to fair value of $0.3 million as of December 31, 2022.

Columbia Warrant

In March 2021, we issued a warrant to purchase up to 15,931,360 shares of our common stock (“Columbia Warrant”) at an exercise price of $2.51635975 per share, or an aggregate of $40.1 million, in connection with the loan agreement between us and Columbia River Investment Limited (“Columbia”).

The Columbia Warrant is exercisable the earlier of 25 years from the effective date or the date in which the warrant is exercised in full.

The Columbia Warrant was initially recognized on March 8, 2021 as a liability with a fair value of $161.2 million, and was remeasured to a fair value of $143.2 million as of December 31, 2021. We recognized a gain from the remeasurement of the Columbia Warrant of $18.6 million for the year ended December 31, 2022. The fair value of the Columbia Warrant of $124.8 million was reclassified to additional paid-in capital in connection with the Merger.

$8.63 Warrants

In connection with the Merger, we entered into an Assignment, Assumption and Amendment Agreement (the “Amended Warrant Agreement”), dated January 25, 2022, with the Sponsor and CF V that amends the Warrant Agreement (the “Existing Warrant Agreement”), dated January 28, 2021.

Pursuant to the Existing Warrant Agreement, we issued Public Warrants to purchase 8,333,333 Class A ordinary shares and 200,000 private placement Warrants. Additionally, we agreed to issue the Forward Purchase Warrant to purchase 333,333 Class A ordinary shares pursuant to the Amended and Restated Forward Purchase Agreement (together, with the Public Warrants and the private placement Warrants, the “$8.63 Warrants”).

All of the $8.63 Warrants are governed by the Existing Warrant Agreement. The $8.63 Warrants became exercisable 30 days after the Closing Date, or February 25, 2022, and will expire five years after the Closing Date (January 25, 2027), or earlier upon redemption or liquidation.

The $8.63 Warrants were initially recognized as a liability with a fair value of $4.9 million. On April 1, 2022, we determined pursuant to a warrant agreement executed by CF V on January 28, 2021, as modified and assumed by an assignment and assumption agreement executed on January 25, 2022, that the warrant price with respect to the warrants issued and outstanding was adjusted from $11.50 to $8.63 and the redemption price was adjusted from $18.00 to $13.50.

Public Warrants to purchase 613,111 Class A ordinary shares were exercised during the year ended December 31, 2022.

Earnout Liabilities

12 Months Ended

Dec. 31, 2022

Earnout Liability [Abstract]

Earnout Liabilities


	Sponsor Earnout		Forfeiture Earnout		Total Earnout Liabilities
As of December 31, 2021	$	—	$	—	$	—
Additions	$	8,022	$	6,135	$	14,157
Change in fair value of financial instruments	(6,669)		(5,130)		(11,799)
Reclassification to equity	—		(1,005)		(1,005)
As of December 31, 2022	$	1,353	$	—	$	1,353

Sponsor Earnout

Pursuant to that certain Sponsor Support Agreement, dated as of July 5, 2021, by and among us, the Sponsor and Nettar, the Sponsor has agreed that during the period between the Closing and the five-year anniversary of the Closing, the Sponsor shall not sell, transfer or otherwise dispose of Class A ordinary shares equal to 1,869,000 less 30% of Forfeiture Escrow Shares retired and canceled (“Sponsor Earnout”). The Sponsor Earnout is subject to potential forfeiture to us for no consideration until the occurrence of each tranche’s respective earnout triggering event. The earnout triggering events related to achieving a closing price at or above $12.50, $15.00 and $20.00 per share, respectively, for any 10 trading days over a 20 trading day period were not satisfied during the year ended December 31, 2022. As a result, the 1,775,962 Class A ordinary shares were not vested and are subject to transfer restrictions and contingent forfeiture provisions.

The estimated fair value of the Sponsor Earnout liability is based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a semi-annual basis over the earnout period, using the most reliable information available. Assumptions used in the valuation are as follows:


	January 25,		December 31,
	2022		2022
Expected term (in years)	5.00		4.07
Dividend yield (%)	—		—
Expected volatility	30	%	50.4	%
Risk-free interest rate	1.6	%	4.1	%
Expected number of shares	1,842,759		1,775,962

Forfeiture Earnout

In connection with the closing of the Merger (the “Closing”), we delivered 310,127 shares of our Class A ordinary shares to an escrow account (“Forfeiture Escrow Shares”). The Forfeiture Escrow Shares were held in escrow for a 30-day adjustment period subsequent to the Closing Date, subject to forfeiture, depending on the VWAP. If the VWAP during the adjustment period was $10.00 or more, all Forfeiture Escrow Shares would be released. For the five-year period following the adjustment period, if the closing price of the shares on the principal exchange or securities market on which such securities are listed or quoted is at or above $15.00 for 10 out of 20 trading days, which do not have to be consecutive, the stockholders will have the right to receive their respective portions of shares back.

The shares were forfeited because the VWAP was below $10.00. The Forfeiture Earnout was initially recognized as a liability with a fair value of $6.1 million. The liability was remeasured to a fair value of $1.0 million at the end of the adjustment period and reclassified as an equity instrument.

Property and Equipment

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Property and Equipment

Property and equipment, net consists of the following:


	Estimated Useful Life (in years)	December 31,
		2022		2021
Satellites in orbit	3	$	54,370	$	43,716
Satellites under construction	Not applicable	22,194		10,558
Leasehold improvements	5-10	6,433		769
Other property and equipment	3-10	4,146		2,138
Total property and equipment		87,143		57,181
Less: Accumulated depreciation		(39,162)		(24,651)
Property and equipment, net		$	47,981	$	32,530

Provisions for depreciation are based on estimated useful lives of the assets using the straight-line method.

Information related to our property and equipment and operating lease ROU assets by geography is as follows:


	December 31,
	2022		2021
Uruguay	$	43,134	$	33,208
Argentina	1,346		1,250
Spain	729		791
Netherlands	9,471		—
Other countries	1,472		236
Total (1) (2) (3)	$	56,152	$	35,485

(1)Non-current assets include property and equipment, net and operating lease right-of-use assets.

(2)The presentation in the table above is based on the geographic location of the entity that holds the assets.

(3)We do not have any non-current assets in the country of incorporation of the holding company.

Additional Financial Statement Information

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Additional Financial Statement Information

Prepaid Expenses and Other Current Assets


	December 31,
	2022		2021
Prepaid expenses and other current assets
Prepaid expenses	$	1,767	$	1,153
Advances to suppliers	588		829
Other current assets	843		713
Total	$	3,198	$	2,695

Accrued Expenses and Other Liabilities


	December 31,
	2022		2021
Accrued expenses and other liabilities
Accrued professional fees related to Merger(1)	$	—	$	16,263
Provisions	71		2,934
Payroll and benefits payable	3,289		2,545
Other taxes payable	3,128		2,045
Other	451		2,200
Total	$	6,939	$	25,987

Total current	$	6,417	$	23,435
Total non-current	$	522	$	2,552

(1)Refer to Note 4 (Reverse Recapitalization) for further details on the Merger.

Finance Costs, Net


	Year Ended December 31,
	2022		2021		2020
Finance costs, net
Interest expense	$	(1,596)	$	(8,729)	$	(43)
Redeemable Series X preferred stock dividends	(97)		(974)		—
Other finance costs	(123)		(71)		—
Interest income	1,164		36		78
Total	$	(652)	$	(9,738)	$	35

Income Tax

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Income Tax

Income TaxWe are incorporated in the BVI. See Item 10.E, “BVI Taxation,” for a description of considerations applicable to BVI taxation. Our operations are conducted through various subsidiaries in a number of countries throughout the world with significant operations in Uruguay, where we operate in a free trade zone. Consequently, income tax has been provided based on the laws and tax rates in effect in the countries in which operations are conducted or in which our subsidiaries are considered resident for corporate income tax purposes, including Argentina, China, Israel, the Netherlands, Spain,

Uruguay, and the United States. Our provision for (benefit from) income tax for the years ended December 31, 2022, 2021 and 2020 is as follows:


	Year Ended December 31,
	2022		2021		2020
Current	$	2,972	$	1,387	$	186
Deferred	1,601		(1,619)		(38)
Total provision for (benefit from) income tax	$	4,573	$	(232)	$	148

We maintain the exception under ASC 740-270-30-36(b), Accounting for Income Taxes, for jurisdictions that do not have reliable estimates of income.

As of December 31, 2022, we have gross unrecognized tax benefits of $3.9 million, exclusive of interest and penalties. If recognized, $2.0 million would reduce our effective tax rate. If applicable, we accrue interest and penalties related to uncertain tax positions as a component of the income tax provision.

A reconciliation of the beginning and ending amounts of our gross unrecognized tax benefits is as follows.


	Year Ended December 31,
	2022
Balance at January 1	$	—
Increases (decreases) in tax positions related to the current period	—
Increases (decreases) in tax positions related to prior periods	3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute	—
Balance at December 31	$	3,889

We did not have any unrecognized tax benefits in 2021 or 2020.

The BVI does not impose an income tax. Our provision for (benefit from) income tax differed from the 0% tax rate imposed in the BVI due to the following items for the years ended December 31, 2022, 2021 and 2020:


	Year Ended December 31,
	2022		2021		2020
Loss before income tax	$	(32,068)	$	(96,537)	$	(21,381)

Provision for (benefit from) income tax at weighted-average statutory rates	—		—		—
U.S. state and local income tax, net of federal benefit	(3)		5		(4)
U.S. foreign-derived intangible income deduction	(141)		(200)		—
Argentina Tax Inflation Adjustment	239		(381)		(198)
Change in valuation allowances	4,283		3,648		1,198
Uncertain tax positions	2,293		—		—
Change in carryforward attributes	(1,740)		—		—
Effect of rates different than statutory	(423)		(3,300)		(828)
Tax credits	(112)		—		—
Other	177		(4)		(20)
Total	$	4,573	$	(232)	$	148

The change in the effective tax rate from December 31, 2021 to December 31, 2022 is primarily related to management’s

decision to record a full valuation allowance on deferred tax assets on a worldwide basis due to the consolidated three-year cumulative loss position.

Deferred tax assets and liabilities as of December 31, 2022 and 2021 consisted of the following:


	December 31,
	2022		2021
Deferred income tax assets:
Stock-based compensation	$	3,023	$	2,053
Bad debt expense	415		407
Deferred financing costs	806		—
Other	193		419
Net operating loss carryforwards	1,365		6,245
Total deferred income tax assets	5,802		9,124
Valuation allowance	(5,802)		(7,484)
Total deferred income tax assets (liabilities), net	$	—	$	1,640

The assessment of the realizability of the deferred income tax assets is based on all available positive and negative evidence. Such evidence includes, but is not limited to, recent cumulative earnings or losses at the worldwide consolidated level, expectations of future taxable income by taxing jurisdiction, and the carry-forward periods available for the utilization of deferred income tax assets. The assessment of the recoverability of deferred income tax assets will not change until there is sufficient evidence to support their realizability.

Below is a summary of our estimated loss and tax credit carryforwards at December 31, 2022. Our tax attributes are subject to limitations on utilization due to historic ownership changes and may be subject to future limitations upon subsequent change of control, as defined by the Internal Revenue Code Sections 382 and 383.


Net Operating Loss	Expiration	Gross Amount Carried Forward		Net Amount Recognized as of December 31, 2022
Argentina	December 31, 2023 - December 31, 2027	$	7,864	$	—
Netherlands	Indefinite	2,856		—
China	December 31, 2026 - December 31, 2027	2,258		—
United States	Indefinite	280		—
Uruguay	December 31, 2026 - December 31, 2027	19		—

As of December 31, 2022 and 2021, we had $13.3 million and $20.9 million of net operating loss (“NOL”) carryforwards, respectively.

In the normal course of business, we are subject to examination by taxing authorities. Tax years vary by jurisdiction, ranging from 2017 to 2022 remaining open for examination.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

Stockholder's Equity (Deficit)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Stockholder's Equity (Deficit)

Stockholders’ Equity (Deficit)

Reverse Recapitalization

The Consolidated Statements of Redeemable Preferred Stock and Stockholders’ Equity (Deficit) reflect the Merger and reverse recapitalization as of January 2022 as discussed in Note 4 (Reverse Recapitalization). Since Satellogic Inc. was determined to be the accounting acquirer in the reverse recapitalization, all periods prior to the consummation of the Merger reflect the balances and activity of Satellogic Inc. (other than shares which were retroactively restated in connection with the Merger).

Preferred Stock

Prior to the Merger, our authorized and issued preferred stock consisted of the following:


	Authorized Shares (prior to Merger)	Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock	4,723,330	2,547,330
Series B preferred stock	3,117,915	1,392,131
Series B-1 preferred stock	899,153	672,524
Total preferred stock	8,740,398	4,611,985

In connection with the Merger, all shares of preferred stock were converted to shares of Class A ordinary shares.

Preferred Stockholder Transaction

In March 2021, we signed an Exchange Agreement (the “Exchange Agreement”) in conjunction with a Loan and Security Agreement and warrant with Columbia River Investment Limited, a holder of preferred stock and convertible notes (the “Investor”), requiring the Investor to sell back to us all its outstanding shares and Notes debt (as part of the sale of such notes to Nettar. For further discussion of the Notes, see Note 17 (Debt).

The Columbia Warrant was initially recognized as a liability. The fair value of the Columbia Warrant was reclassified to additional paid-in capital in connection with the Merger. See Note 6 (Warrant Liabilities) for further information relating to the Columbia Warrant.

Common Stock

Our registration statement was filed on May 2, 2022 and was declared effective on May 9, 2022.

We are authorized to issue unlimited Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. As of December 31, 2022, there were 75,612,795 Class A ordinary shares issued and outstanding.

In addition, we are authorized to issue unlimited Class B ordinary shares with a par value of $0.0001 per share. Holders of Class B ordinary shares are entitled to 1.472467906 votes per share. Satellogic’s founder and Chief Executive Officer owns 13,582,642 Class B ordinary shares, representing 100% of the voting power of the Class B ordinary shares and 20.9% of the voting power of Satellogic’s common stock.

Holders of Class B ordinary shares have a number of votes per share equal to the number of votes controlled by the Liberty Investor. Class B ordinary shares will automatically convert to Class A ordinary shares at the five-year anniversary of the Closing Date unless otherwise converted, generally at the holder’s option.

Treasury Stock

On February 14, 2022, our board of directors approved an initial $5 million share repurchase program. Repurchases under the program may be made in the open market, in privately negotiated transactions or otherwise, with the timing of repurchases depending on market conditions.

We repurchased 516,123 Class A ordinary shares for $2.7 million during the year ended December 31, 2022.

Hannover Holdings TransactionWe repurchased 51,700 Class A ordinary shares, 134,735 shares of Series A preferred stock, and 15,082 shares of Series B-1 preferred stock from Hannover Holdings S.A. prior to the consummation of the Merger for an aggregate of $5,853 (the “Hannover Holdings Transaction”).

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

Stock-based Compensation

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Stock-based Compensation

Our employees, including senior executives, receive incentives in the form of stock options and RSUs, whereby employees render services as consideration for equity instruments (equity-settled transactions).

On the Closing Date, we established the 2021 Incentive Compensation Plan (the “2021 Plan”) under which RSUs were issued during the year ended December 31, 2022. The 2021 Plan provides for the grant options, stock appreciation rights, restricted stock awards, RSUs, shares granted as a bonus or in lieu of another award, dividend equivalents, or other stock-based awards or performance awards at the discretion of a board-elected committee. We also maintain our 2015 Share Plan as amended (the “2015 Plan”) under which stock-based option awards were issued or modified. The options were typically granted with a four-year vesting term and a maximum contractual term of 10 years. As of December 31, 2022, no further awards have or shall be granted under the 2015 Share Plan. There were no options granted during the year ended December 31, 2022.

A summary of stock option activity for the year ended December 31, 2022 is as follows:


	Number of Options	Weighted-Average Exercise Price	Weighted-Average Remaining Contractual Term (years)	Intrinsic Value (in thousands)
Balance as of December 31, 2021	6,864,563	$2.05	2.36
Granted	—	—
Forfeited	(574,299)	4.56
Exercised	(102,825)	1.12
Expired	(120,126)	2.60
Outstanding at December 31, 2022	6,067,313	$1.83	2.07	$	10,818
Exercisable at December 31, 2022	4,449,152	$1.31	1.92	$	8,832

The total intrinsic value of options exercised during the years ended December 31, 2022, 2021 and 2020 was $75 thousand, $23.9 million and $9.7 million , respectively. The number of options exercised is net of 17,376 options forfeited for payment of withholding taxes.

The following table lists the inputs used under the Black-Scholes model for stock-option awards during the years ended December 31, 2022, 2021, and 2020, respectively:


	Year Ended December 31,
	2022			2021		2020
Weighted-average fair value of options at the measurement date (grant date)	$	—		$	23.36	$	6.31
Dividend yield (%)	—			—		—
Expected volatility (%)	—		%	61 - 72		59 - 61
Risk-free interest rate (%)	—		%	0.5 - 1.4		0.4 - 0.5
Weighted average share price	$	—		$	6.79	$	2.75

As further detailed in Note 4 (Reverse Recapitalization), all options to purchase the predecessor common stock were assumed by Satellogic Inc., the new listed company, and became options to purchase Class A ordinary shares of Satellogic Inc., as determined in accordance with the Merger Agreement. There were no other material cancellations or modifications to the granted awards for the years ended December 31, 2022, 2021, and 2020.

A summary of RSU activity for the year ended December 31, 2022 is as follows:


	Number of RSUs	Intrinsic Value (in thousands)
Outstanding unvested RSUs at December 31, 2021	—
Granted during the year	1,640,496
Forfeited during the year	(60,823)
Vested during the year	(120,393)
Expired during the year	—
Outstanding unvested RSUs at December 31, 2022	1,459,280	$1,940

The weighted-average exercise price of RSUs at December 31, 2022 was $4.38. The number of shares vested is net of 56,649 options forfeited for payment of withholding taxes.

As of December 31, 2022, unrecognized stock-based compensation cost related to outstanding options and RSUs that are expected to vest was $3.2 million and $5.4 million, respectively, which is expected to be recognized over a weighted-average period of 1.42 years and 1.44 years, respectively.

Stock-based Compensation Expense

Total employee and non-employee stock-based compensation expense for the years ended December 31, 2022, 2021, and 2020 was classified in the Consolidated Statements of Operations and Comprehensive Loss as follows:


	Year Ended December 31,
	2022		2021		2020
General and administrative expenses	$	2,406	$	5,274	$	1,235
Research and development	3,631		1,968		382
Other operating expenses	2,331		3,639		115
Total	$	8,368	$	10,881	$	1,732

Redeemable Preferred Stock	12 Months Ended
Redeemable Preferred Stock	Dec. 31, 2022
Temporary Equity Disclosure [Abstract]
Redeemable Preferred Stock	Redeemable Preferred Stock Reverse Recapitalization The redeemable Series X preferred stock, par value of $0.0001, carried an annual 7% cumulative dividend, payable upon a liquidation, dissolution, winding up or, upon the election of the stockholders, upon redemption. Due to the contractual provisions of the redeemable Series X preferred stock, the Series X preferred stock was accounted for as mezzanine equity. Upon Closing, we canceled and converted all 2,033,230 shares of issued and outstanding redeemable Series X preferred stock and preferred dividends amounting to $21.4 million into 2,140,340 shares of Satellogic Class A ordinary shares, based on the conversion price of $10.00 per share, at the time the Merger became effective. As of December 31, 2022, there were no issued and outstanding shares of redeemable Series X preferred stock.

Net Loss Per Share

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Net Loss Per Share

The weighted-average number of shares of common stock outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio of 3.3028 (“Exchange Ratio”) to give effect to the reverse recapitalization treatment of the Merger. Shares of common stock issued as a result of redeemable Series X preferred stock and the conversion of shares of preferred stock outstanding pre-Merger in connection with the Closing have been included in the basic net loss per share calculation on a prospective basis.

Diluted loss per share considers the impact of potentially dilutive securities. We identified financial instruments that qualify as potential common shares: (i) the share-based options awards described in Note 12 (Stock-based Compensation), (ii) the warrants described in Note 6 (Warrant Liabilities), and (iii) the earnout liabilities described in Note 7 (Earnout Liabilities). With the exception of the Columbia Warrant, each of these potential common shares are antidilutive since their conversion to common shares would decrease loss per share from continuing operations.

The Columbia Warrant was dilutive due to the change in fair value of financial instruments during the years ended December 31, 2022 and 2021.

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:


	Year Ended December 31,
	2022		2021		2020
Net loss attributable to common stockholders	$	(36,641)	$	(96,305)	$	(21,529)
Basic weighted-average common shares outstanding (1)	83,188,276		16,655,634		16,029,826
Basic loss per share for the period attributable to common stockholders	$	(0.44)	$	(5.78)	$	(1.34)
Effect of dilutive securities:
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$	(18,635)	$	—	$	—
Dilutive numerator	$	(55,276)	$	(96,305)	$	(21,529)
Columbia Warrant	609,873		—		—
Diluted weighted-average common shares outstanding	83,798,149		16,655,634		16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(0.66)	$	(5.78)	$	(1.34)

1 After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Additionally, the following securities were not included in the computation of diluted shares outstanding because the effect would have been anti-dilutive:


	Year Ended December 31,
	2022	2021	2020
Warrants	49,184,868	15,931,360	—
Sponsor earnout shares	1,775,962	—	—
Stock options	6,067,313	6,864,563	4,694,314
Restricted stock units	1,459,280	—	—
Redeemable convertible preferred stock	—	6,645,215	8,740,398
Total	58,487,423	29,441,138	13,434,712

Fair Value Measurements and Financial Instruments

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements and Financial Instruments

The following tables provide the fair value measurement hierarchy of our assets and liabilities:


As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability	—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability	—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout liability	$	—	$	—	$	1,353


As of December 31, 2021	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Liabilities measured at fair value
Cantor Loan	$	—	$	—	$	7,522
Columbia Warrant liability	—		—		143,237
Liabilities for which fair values are disclosed
Notes	$	—	$	180,356	$	—
Promissory notes	—		40,925		—

The following methods and assumptions were used to estimate the fair values:

•The carrying values of cash and cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, and accrued expenses and other liabilities are considered to approximate their fair values due to the short-term nature of these items.

•The fair values of the PIPE Warrant, the Liberty Warrants and Liberty Advisory Fee Warrant, and the Columbia Warrant have been estimated using the Black-Scholes model.

•The fair value of the Sponsor Earnout has been estimated using the Monte Carlo model.

•The fair values of the $8.63 Warrants were determined using the quoted prices in the active warrant market.

•The carrying value of operating lease liabilities is calculated as the present value of lease payments, discounted at its incremental borrowing rate at the lease commencement date. We consider that the incremental borrowing rate remained unchanged, therefore the carrying amount of operating lease liabilities approximates its fair value.

•The fair value of the Cantor Loan was determined by using the “with” method. At each measurement date, we valued the Cantor Loan with the make-whole premium. The difference between the aggregate fair value of the Cantor Loan and the unpaid principal balance was $22 thousand at December 31, 2021.

•The fair value of the Notes debt is determined by using the “with” and “without” method. As of each measurement date, we first valued the Notes with the conversion options in certain scenarios (the “with” scenario) and subsequently valued the Notes without the conversion options (the “without” scenario). The difference between the fair values of the Notes in the “with” and “without” was de minimis at each measurement date.

Changes in the fair value of Level 3 liabilities during the years ended December 31, 2022 and 2021 were as follows:


	Liberty Warrants and Liberty Advisory Fee Warrant		PIPE Warrant		Columbia Warrant		Sponsor Earnout		Forfeiture Earnout		Cantor Loan
At January 1, 2021	$	—	$	—	$	—	$	—	$	—	$	—
Issues	—		—		161,432		—		—		7,513
Remeasurement (gain)/loss(1)	—		—		(17,992)		—		—		9
Amortization of deferred costs	—		—		(203)		—		—		—
At December 31, 2021	—		—		143,237		—		—		7,522
Issues	30,853		1,312		—		8,022		6,135		—
Remeasurement (gain)/loss(1)	(24,662)		(1,001)		(18,635)		(6,669)		(5,130)		488
Write-off of deferred costs	—		—		203		—		—		—
Settlements (2)	—		—		(124,805)		—		(1,005)		(8,010)
At December 31, 2022	$	6,191	$	311	$	—	$	1,353	$	—	$	—

(1)Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.

(2)These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

There were no transfers between Level 1 and Level 2 during the years ended December 31, 2022 or 2021.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Related Parties

12 Months Ended

Dec. 31, 2022

Related Parties

We had convertible notes with certain related parties at December 31, 2021. The convertible notes were settled in connection with the Merger. See Note 4 (Recapitalization Transaction). The following table provides the balances owed and associated finance costs as follows:


	December 31,
	2022		2021		2020
Convertible notes debt from related parties
Amounts owed to related parties	$	—	$	13,028	$	—
Interest expense	$	554	$	620	$	591

There are no sales or purchases transactions with entities with significant influence over us or our key management personnel.

See description of transactions with CF&Co and Liberty Investment as part of the Merger Transaction described in Note 4 (Reverse Recapitalization).

We made purchases totaling $456 from our equity method investee, OS, during the period beginning on the investment date to December 31, 2022. See Note 21 (Equity Method Investment).

Debt

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Debt

There was no debt as of December 31, 2022. Debt as of December 31, 2021 is as follows:


	December 31, 2021
2018 Convertible Notes	$	19,862
2019 Convertible Notes	27,498
2020 Convertible Notes	15,294
Cantor Loan	7,522
Columbia Loan	38,297
Total debt	108,473
Less deferred financing costs	—
Total debt less deferred financing fees	108,473
Less: Current portion	—
Total non-current debt, net of deferred financing fees	$	108,473

Convertible Notes

In April 2021, we and our 2018 and 2019 convertible note holders agreed to extend the maturity date of the 2018 and 2019 convertible notes from April and September 2021, respectively, to April 2022, and recognized a loss on extinguishment of debt of $37,216 on the Consolidated Statements of Operations and Comprehensive Loss for the year ended December 31, 2021.

On January 25, 2022, the convertible notes were converted into 17,980,954 Class A ordinary shares. See Note 4 (Reverse Recapitalization).

Cantor Loan

In December 2021, we entered into the Cantor Loan. As we elected to account for the Cantor Loan using the fair value option at inception, changes in fair value recognized through subsequent remeasurements were recorded in the Consolidated Statements of Operations and Comprehensive Loss at each reporting period.

Pursuant to the Promissory Note Waiver Letter, the Company repaid the Cantor Loan, including all principal and interest, by the issuance of 788,021 Class A ordinary shares. Such repayment occurred on the Closing Date.

The Promissory Note Waiver Letter included a provision where in the event the VWAP is less than $10.00 per Class A ordinary share, CF&Co. will be entitled to receive a certain number of additional Class A ordinary shares (the “Cantor Loan Additional Shares”), up to a maximum of 197,005 Cantor Loan Additional Shares (if the Adjustment Period VWAP, as defined in the Promissory Note Waiver Letter, is less than or equal to $8.00 per share).

We extinguished the remaining Cantor Loan liability through the issuance of 26,050 Cantor Loan Additional Shares on May 9, 2022 pursuant to the terms of the Promissory Note Waiver Letter.

Columbia Loan

On March 8, 2021, we signed an Exchange Agreement in conjunction with a Loan and Security Agreement and warrant with Columbia, a holder of Series A, Series B and Series B-1 preferred shares and convertible notes. The Exchange Agreement requires Columbia to sell back to us all its outstanding shares and Notes debt, in exchange for a loan and security interest in the principal amount of $40.1 million (the “Columbia Loan”), which represented the outstanding balance of the notes including unpaid accrued interest, in exchange for the Columbia Warrant. In connection with the Merger and as provided in the Exchange Agreement, we reacquired treasury stock having a fair value of $170.9 million, the Columbia Loan was settled and the fair value of the Columbia Warrant of $124.8 million was reclassified to additional

paid-in capital. There is no balance outstanding remaining at December 31, 2022 related to the Columbia Loan or Columbia Warrant liability.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI https://asc.fasb.org/topic&trid=2208564

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1C
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1E
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1I
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 1B
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611

+ Details

Leases

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Leases

We have operating leases for property and equipment. Lease terms range from two years to 10 years.

Changes in our operating lease ROU assets carrying amounts were as follows:


	December 31,
	2022		2021
Balance as of beginning of period	$	2,955	$	1,403
Lease expense	(1,701)		(494)
Foreign exchange differences	115		(48)
Additions	7,171		2,119
Disposals	(322)		—
Transfers	(47)		(25)
Balance as of end of period	$	8,171	$	2,955

Changes in our operating lease liabilities carrying amounts were as follows:


	December 31,
	2022		2021
Balance as of beginning of period	$	3,068	$	1,415
Additions to operating lease liabilities	7,171		2,119
Lease expense	314		54
Foreign exchange differences	(293)		(48)
Disposals	(329)		—
Payments	(1,692)		(472)
Balance as of end of period	$	8,239	$	3,068

Total current	$	2,176	$	985
Total non-current	6,063		2,083

We recognized in the Consolidated Statements of Operations and Comprehensive Loss the following expenses related to our operating leases for the years ended December 31, 2022, 2021 and 2020:


	Year Ended December 31,
	2022		2021		2020
Right-of-use assets	$	1,701	$	494	$	247
Operating lease liabilities	314		54		51
Total lease expense	$	2,015	$	548	$	298

The amounts of future undiscounted cash flows related to the lease payments over the lease term and the reconciliation to the present value of the operating lease liabilities at December 31, 2022 is as follows:


	Operating leases
Years Ended
2023	$	2,484
2024	2,235
2025	824
2026	603
2027 and thereafter	3,166
Total remaining lease payments	9,312
Less imputed interest	(1,073)
Present value of lease liability	$	8,239

Total current	$	2,176
Total non-current	$	6,063

The weighted-average remaining years for the operating leases are 5.66. The weighted-average discount rate for operating leases is 4.6%.

Adoption of U.S. GAAP

12 Months Ended

Dec. 31, 2022

Adoption of U.S. GAAP [Abstract]

Adoption of U.S. GAAP

Accounting Standards Updates (“ASU”)

Accounting Standards Recently Adopted

Accounting Standards Not Yet Adopted

Adoption of U.S. GAAP

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2021:


	Year Ended December 31, 2021
	IFRS		Adjustments/ Reclassifications		Note	U.S. GAAP
Revenue	$	4,247	$	—		$	4,247
Costs and expenses
Cost of sales	1,876		—			1,876
General administrative expenses	36,649		(9)		a, c	36,640
Research and development	9,640		(4)		b	9,636
Depreciation expense	10,825		(97)		b	10,728
Other operating expenses, net	14,002		—			14,002
Total costs and expenses	72,992		(110)			72,882
Operating loss	(68,745)		110			(68,635)
Other income (expense), net
Finance costs, net	(11,769)		2,031		c, d	(9,738)
Change in fair value of financial instruments	(42,102)		60,085		d	17,983
Gain (loss) on extinguishment of debt	3,576		(40,792)		d	(37,216)
Other income (expense), net	1,067		2		c	1,069
Total other income (expense), net	(49,228)		21,326			(27,902)
Loss before income tax	(117,973)		21,436			(96,537)
Income tax	232		—			232
Net loss available to common stockholders	$	(117,741)	$	21,436		$	(96,305)
Other comprehensive loss
Foreign currency translation loss, net of tax	(86)		—			(86)
Comprehensive loss	$	(117,827)	$	21,436		$	(96,391)

Basic loss for the period attributable to common stockholders	$	(7.07)	$	1.29	e	$	(5.78)
Basic weighted-average common shares outstanding	16,655,634		—		e	16,655,634
Diluted loss for the period attributable to common stockholders	$	(7.07)	$	1.29	e	$	(5.78)
Diluted weighted-average common shares outstanding	16,655,634		—		e	16,655,634

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2020:


	Year Ended December 31, 2020
	IFRS		Adjustments/ Reclassifications		Note	U.S. GAAP
Revenue	$	—	$	—		$	—
Costs and expenses
Cost of sales	—		—			—
General administrative expenses	8,127		(124)		a, c	8,003
Research and development	5,878		46		a, b	5,924
Depreciation expense	3,182		(151)		b	3,031
Other operating expenses, net	5,476		(27)		a, b	5,449
Total costs and expenses	22,663		(256)			22,407
Operating loss	(22,663)		256			(22,407)
Other income (expense), net
Finance costs, net	(22)		57		c, d	35
Change in fair value of financial instruments	(84,224)		93,861		d	9,637
Gain (loss) on extinguishment of debt	(7,466)		(1,774)		d	(9,240)
Other income (expense), net	597		(3)		c	594
Total other income (expense), net	(91,115)		92,141			1,026
Loss before income tax	(113,778)		92,397			(21,381)
Income tax	(148)		—			(148)
Net loss available to common stockholders	$	(113,926)	$	92,397		$	(21,529)
Other comprehensive loss
Foreign currency translation loss, net of tax	—		—			—
Comprehensive loss	$	(113,926)	$	92,397		$	(21,529)

Basic loss for the period attributable to common stockholders	$	(7.11)	$	5.76	e	$	(1.34)
Basic weighted-average common shares outstanding	16,029,826		—		e	16,029,826
Diluted loss for the period attributable to common stockholders	$	(7.11)	$	5.76	e	$	(1.34)
Diluted weighted-average common shares outstanding	16,029,826		—		e	16,029,826

Reconciliation of the Consolidated Balance Sheet as of December 31, 2021:


	IFRS		Adjustments / Reclassifications		Note	U.S. GAAP
ASSETS
Current assets
Cash and cash equivalents	$	8,533	$	—		$	8,533
Accounts receivable	1,196		—			1,196
Prepaid expenses and other current assets	2,695		—			2,695
Total current assets	12,424		—			12,424
Property and equipment, net	33,586		(1,056)		b	32,530
Operating lease right-of-use assets	2,663		292		c	2,955
Deferred income tax assets	1,640		—			1,640
Other non-current assets	369		—			369
Total assets	$	50,682	$	(764)		$	49,918
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	6,650	$	—		$	6,650
Debt	246,189		(137,716)		d	108,473
Warrant liabilities	—		143,237		d	143,237
Operating lease liabilities	891		94		c	985
Contract liabilities	935		—			935
Accrued expenses and other liabilities	23,435		—			23,435
Total current liabilities	278,100		5,615			283,715
Operating lease liabilities	1,908		175		c	2,083
Contract liabilities	1,000		—			1,000
Other non-current liabilities	2,552		—			2,552
Total liabilities	283,560		5,790			289,350
Redeemable preferred stock	—		21,306		d	21,306
Stockholders' equity (deficit)
Treasury stock	(170,949)		—			(170,949)
Additional paid-in capital	235,909		(139,438)		a, d	96,471
Accumulated other comprehensive loss	(86)		—			(86)
Accumulated deficit	(297,752)		111,578			(186,174)
Total stockholders’ equity (deficit)	(232,878)		(27,860)			(260,738)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	50,682	$	(764)		$	49,918

a.Stock-based compensation

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
General and administrative expenses	$	(80)	$	(136)
Research and development	—		(89)
Other operating expenses	—		(27)
Increase (decrease) to loss before income tax	$	(80)	$	(252)


(Consolidated Balance Sheet)	December 31, 2021
Additional paid-in-capital	$	542
Adjustment to accumulated deficit	(542)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	—

b.Research and development

Under IFRS, certain development expenditures may be capitalized. Under U.S. GAAP, all of our costs relating to R&D activities are expensed as incurred.

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
Research and development	$	(4)	$	135
Depreciation expense	(97)		(151)
Other operating expenses	—		—
Increase (decrease) to loss before income tax	$	(101)	$	(16)


(Consolidated Balance Sheet)	December 31, 2021
Property and equipment, net	$	(1,056)
Total assets	$	(1,056)
Adjustment to accumulated deficit	$	(1,056)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	(1,056)

c.Leases

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
General and administrative expenses	$	71	$	12
Less: Finance costs, net	(49)		(57)
Less: Other income, net	(2)		3
Increase (decrease) to loss before income tax	$	20	$	(42)


(Consolidated Balance Sheet)	December 31, 2021
Operating lease right-of-use assets	$	292
Total assets	$	292
Operating lease liabilities	$	94
Non-current operating lease liabilities	175
Adjustment to accumulated deficit	23
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	292

d.Financial instruments

Additionally, the resulting gain (loss) on extinguishment of the amended convertible notes differed under IFRS versus U.S. GAAP.

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statements of Operations and Comprehensive Loss)	2021		2020
Less: Finance costs, net	$	(1,982)	$	—
Less: Change in fair value of financial instruments	(60,085)		(93,861)
Less: Gain (Loss) on extinguishment of debt	40,792		1,774
Increase (decrease) to loss before income tax	$	(21,275)	$	(92,087)


(Consolidated Balance Sheet)	December 31, 2021
Debt	$	(137,716)
Redeemable Series X preferred stock	21,306
Warrant liability	143,237
Additional paid-in capital	(139,980)
Adjustment to accumulated deficit	113,153
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	—

e.Net loss per share

The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:


	Year Ended December 31,
	2021		2020
Net loss attributable to common stockholders	$	(96,305)	$	(21,529)
Basic weighted-average common shares outstanding (1)	16,655,634		16,029,826
Basic loss per share for the period attributable to common stockholders	$	(5.78)	$	(1.34)

Dilutive numerator	$	(96,305)	$	(21,529)
Diluted weighted-average common shares outstanding	16,655,634		16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(5.78)	$	(1.34)

(1) After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

- Definition

+ References

+ Details

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Contingencies We may be named from time to time as a party to lawsuits arising in the ordinary course of business related to its sales, marketing, and the provision of its services and equipment. Litigation and contingency accruals are based on our assessment, including advice of legal counsel, regarding the expected outcome of litigation or other dispute resolution proceedings. If we determine that an unfavorable outcome is probable and can be reasonably assessed, we establish the necessary accruals. As of December 31, 2022 and December 31, 2021, we are not aware of any contingent liabilities that should be reflected in the Consolidated Financial Statements.

Equity Method Investment	12 Months Ended
Equity Method Investment	Dec. 31, 2022
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investment	Equity Method InvestmentOn May 6, 2022, we entered into an Investment Agreement with OS, a company engaged in the design and production of telescopes and opto-mechanical and aerospace instrumentation for ground and space-based applications, to purchase 5% of OS’s outstanding common shares for $3.7 million. Additionally, OS issued 524,715 stock warrants to us, giving us the right to convert each warrant into a single common share over a period of up to 36 months. Emiliano Kargieman, our Chief Executive Officer, was appointed to OS’s board of directors. The investment was completed on September 30, 2022.

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn March 8, 2023, we filed an amendment to our memorandum and articles of association. The amendment updated the voting multiplier for our Class B shares from 1.463844005 to 1.472467906. The amended and restated memorandum and articles of association are included as Exhibit 1.1 to this Report.

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	The accompanying Consolidated Financial Statements as of December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020 (“the Consolidated Financial Statements”) have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The Company conducts business through one operating segment.
Consolidation	The accompanying Consolidated Financial Statements include our accounts and those of our wholly owned subsidiaries. All intercompany accounts and transactions, including the intercompany portion of transactions with equity method investees, have been eliminated in consolidation. The Consolidated Financial Statements are presented in United States dollars (hereinafter “U.S. dollars” or “$”).
Reclassification	Certain prior year amounts have been reclassified to conform to the current year presentation.
Use of Estimates	Use of Estimates The preparation of the Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions reflected in these Consolidated Financial Statements include, but are not limited to, revenue recognition; determination of useful lives of property and equipment; valuation of warrant liabilities, earnout liabilities, stock options; and determination of income tax. We evaluate our estimates and assumptions on an ongoing basis. Actual results could differ from those estimates and such differences may be material to the Consolidated Financial Statements.
Revenue Recognition	Revenue Recognition We recognize revenue in accordance with Topic 606 Revenue from contracts with customers. Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that we expect to receive in exchange for goods or services provided under such contracts. We apply the following five-step model in order to determine this amount: (i) identification of the promised goods in the contract; (ii) determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) we satisfy each performance obligation. Our main revenue stream is from services. We recognize as revenues the amount of the transaction price that is allocated to the respective performance obligation when or as the performance obligation is satisfied. Generally, our performance obligations are transferred to customers at a point in time, typically upon delivery. Our satellite imagery can be delivered to customers in two ways, either by providing access via our platform or via electronic delivery. The nature of our contracts does not currently give rise to variable consideration related to returns or refunds as those are not offered. We evaluate contracts with a minimum purchase commitment to determine whether we expect to be entitled to a breakage amount. We consider the requirements on constraining estimates variable consideration. The following factors are evaluated when assessing the increased likelihood of a significant revenue reversal: (i) the amount of consideration is highly susceptible to factors outside our influence or control (e.g., volatility in a market, judgment of action of third parties, weather conditions), (ii) uncertainty about the amount of consideration is not expected to be resolved for a long period of time, (iii) our experience with similar types of contracts is limited, or that experience has limited predictive value, (iv) we have a practice of either offering a broad range of price concessions or changing the payment terms and conditions of similar contracts in similar circumstances, and (v) the contract has a large number and broad range of possible consideration amounts. We exclude amounts collected on behalf of third parties, such as sales taxes, when determining transaction price. Contract liabilities consist of payments received from customers, or such consideration that is contractually due, in advance of providing the product or performing services. We generally do not enter into long-term financing arrangements or payment plans with customers. Although our business practice is not to enter into contracts with non-cash consideration, at times this may occur. In these instances, we determine the fair value of the non-cash consideration at contract inception and includes this value as part of the total arrangement consideration. In instances where we cannot reasonably estimate the fair value of the non-cash consideration, we will measure the consideration indirectly by reference to its stand-alone selling price of the goods promised to the customer in exchange for consideration.
Fair Value Measurement	Fair Value Measurement Certain assets and liabilities are carried at fair value in accordance with U.S. GAAP. Valuation techniques used to measure fair value requires us to utilize observable and unobservable inputs. The hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Financial instruments carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: •Level 1: Quoted prices in active markets for identical assets or liabilities. •Level 2: Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable. •Level 3: Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable. Assets and liabilities recognized at fair value on a recurring basis in the Consolidated Financial Statements are re-assessed at the end of each reporting period to determine whether any transfers have occurred between levels in the hierarchy. For fair value disclosures, classes of assets and liabilities are based on the nature, characteristics and risks of the asset or liability and the level of the fair value hierarchy.
Credit Risk Management	Credit risk management Credit risk is the risk that a counterparty fails to discharge an obligation to us. We are exposed to credit risk from financial assets including cash, cash equivalents and restricted cash held at banks, trade and other receivables. The credit risk is managed based on our credit risk management policies and procedures. Credit risk of any entity doing business with us is systematically analyzed, including aspects of a qualitative nature. The measurement and assessment of our total exposure to credit risk covers all financial instruments involving any counterparty risk. The credit risk in respect of cash balances held with banks and deposits with banks are managed via diversification of bank deposits and are only with major reputable financial institutions. As our risk exposure is mainly influenced by the individual characteristics of each customer, we continuously analyze the creditworthiness of significant debtors. Accounts receivable are non-interest bearing and generally on terms of 30 to 90 days.
Impairments of Assets	Impairment of Assets We assess potential impairments to long-lived assets whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable. An impairment is considered to exist if the total estimated future cash flows on an undiscounted basis are less than the carrying amount of the assets or asset group. We performed an impairment test as of December 31, 2022, 2021 and 2020 due to our net loss for those years and concluded that the asset group is not impaired. Estimates of future cash flows are highly subjective judgments based on management’s experience and knowledge of the Company's operations. These estimates can be significantly impacted by many factors, including changes in global economic conditions, operating costs, obsolescence of technology and competition. If estimates or underlying assumptions change in the future, we may be required to record impairment charges. If the fair value of an asset group is less than its carrying amount, then the carrying amount of the asset group would be reduced to its fair value. That reduction is an impairment loss that would be recognized in the Consolidated Statements of Operations and Comprehensive Loss
Equity Method Investments	Equity Method Investments We account for equity investments in which we have significant influence, but not a controlling financial interest, using the equity method of accounting. Under the equity method of accounting, investments are initially recorded at cost, less impairment, and subsequently adjusted to recognize our share of earnings or losses as a component of Other income (expense), net in the Consolidated Statements of Operations and Comprehensive Loss. Our equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in value. We have not recorded any impairment losses related to our equity method investments during the year ended December 31, 2022. We did not hold any equity investments in 2021 or 2020.
Stock-Based Compensation	Stock-Based Compensation We measure and recognize all stock-based compensation expense based on estimated fair values for all stock-based awards made to employees and non-employees. Compensation cost is recognized over the requisite service period for each separate tranche, as though each tranche of the award is, in substance, a separate award. The expense calculation includes estimated forfeiture rates, which have been developed based upon historical experience. The fair values for stock options are calculated using the Black-Scholes option pricing model using the following inputs: Expected term - The simplified method is used to calculate the expected term. Expected volatility - We determine the expected stock price volatility based on the historical volatilities of guideline companies from comparable industries. Expected dividend yield - We do not use a dividend rate due to the fact that we have never declared or paid cash dividends on the Company’s common stock and we do not anticipate doing so in the foreseeable future. Risk-free interest rate - We base our interest rate on a treasury instrument for which the term is commensurate with the maximum expected life of the stock options.
Foreign Currencies	Foreign Currencies The financial position and results of operations of certain of our foreign subsidiaries are measured using the local currency as the functional currency. Revenues and expenses of these subsidiaries have been translated into U.S. dollars at average exchange rates prevailing during the period. Assets and liabilities of these subsidiaries have been translated at the exchange rates as of the balance sheet date. Translation gains and losses are recorded in accumulated other comprehensive loss. Aggregate foreign currency gains and losses, such as those resulting from the settlement of receivables or payables, foreign currency contracts and short-term intercompany advances in a currency other than the relevant subsidiary’s functional currency, are recorded currently in the Consolidated Statements of Operations and Comprehensive Loss (included in other income, net) and resulted in gains of $1,576, $1,022, and $594 during the years ended December 31, 2022, 2021, and 2020, respectively.
Leases	Leases We determine if a contract is a lease or contains a lease at inception. On the lease commencement date, we recognize a right-of-use (“ROU”) asset and lease liability related to operating type leases. The cost of ROU assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Operating lease liabilities are recorded based on the present value of the future lease fixed payments. In determining the present value of future lease payments, we use our incremental borrowing rate applicable to the economic environment and the duration of the lease based on the information available at the commencement date as the majority of leases do not provide an implicit rate. For real estate and equipment contracts, we generally account for the lease and non-lease components as a single lease component. In assessing the lease term, we include options to renew only when we are reasonably certain that such option(s) will be exercised; a determination which is at our sole discretion. Variable lease payments are recognized as expenses in the period incurred. For leases with an initial term of 12 months or less, we have elected to not record an ROU asset and lease liability. We record lease expense on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets, beginning on the commencement date. We remeasure and reallocate the consideration in a lease when there is a modification of the lease that is not accounted for as a separate contract. The lease liability is remeasured when there is a change in the lease term or in the assessment of whether we will exercise a lease option. We assess ROU assets for impairment in accordance with our long-lived asset impairment policy. We account for lease agreements with contractually required lease and non-lease components on a combined basis. Lease payments made for cancellable leases, variable amounts that are not based on an observable index and lease agreements with an original duration of less than 12 months are recorded directly to lease expense. For the periods presented, we do not have any financing type leases.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are stated at the amount owed by the customer, net of allowances for estimated doubtful accounts, discounts, returns and rebates. We measure the allowance for doubtful accounts based on the estimated loss. In calculating an allowance for doubtful accounts, we use our historical experience, external indicators and an aging method. We assess impairment of trade accounts receivable on a collective basis as they possess shared credit risk characteristics which have been grouped based on the days past due. Accounts are written off against the allowance account when they are determined to be no longer collectible.
Cash, Cash Equivalents	Cash and cash equivalents include deposits in banks and short-term (original maturities of three months or less at the time of purchase), highly liquid investments that are readily convertible to known amounts of cash with a maturity of three months or less at the time of purchase.
Restricted Cash	Restricted cash, including amounts in Other non-current assets, represents amounts pledged as guarantees for sales and lease agreements as contractually required.
Accounting Standards Recently Adopted and Accounting Standards Not Yet Adopted	Accounting Standards Recently Adopted In May 2021, the FASB issued ASU 2021-04, Earnings per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40), which clarifies and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified upon modification or exchange. This ASU is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity applies the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements. In January 2020, the FASB issued ASU 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of accounting for equity securities, investments accounted for under the equity method of accounting, and the accounting for certain forward contracts and purchase options, under the aforementioned topics. This ASU is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity applies the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”) which is part of the FASB’s overall simplification initiative to reduce the costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. ASU 2019-12 simplifies accounting guidance for intra-period allocations, deferred tax liabilities, year-to-date losses in interim periods, franchise taxes, step-up in tax basis of goodwill, separate entity financial statements, and interim recognition of tax laws or rate changes. ASU 2019-12 is effective for emerging growth companies following private company adoption dates in fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. We adopted this guidance as of January 1, 2022. The impact of adopting this new guidance was not material to the consolidated financial statements. Accounting Standards Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses to estimate credit losses on certain types of financial instruments, including trade receivables, resulting in an earlier recognition of losses than under the current incurred loss approach, which requires waiting to recognize a loss until it is probable of being incurred. This standard is effective for us beginning January 1, 2023 and will be adopted using the modified retrospective transition method through a cumulative-effect adjustment to retained earnings as of the effective date. Upon adoption, the standard is expected to only impact our account for credit losses related to accounts receivable. In preparation for the adoption of the new standard, we have updated certain policies and related processes, but we do not expect the adoption of this new guidance will have a material impact on the Consolidated Financial Statements.

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Summary of Allowance for Credit Losses

The following table shows the activity in the allowance for doubtful accounts for the years ended December 31, 2022 and 2021:


	December 31,
	2022		2021
Allowance for doubtful accounts as of beginning of period	$	1,794	$	—
Provision	1,736		1,794
Write-offs	—		—
Foreign exchange and other	(293)		—
Allowance for doubtful accounts as of end of period	$	3,237	$	1,794

Schedule of Cash and Cash Equivalents


	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash	126		—
Restricted cash included in Other non-current assets	1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Schedule of Restrictions on Cash and Cash Equivalents


	December 31,
	2022		2021
Cash and cash equivalents	$	76,528	$	8,533
Restricted cash	126		—
Restricted cash included in Other non-current assets	1,138		—
Total cash, cash equivalents and restricted cash	$	77,792	$	8,533

Schedule of Cash Flow, Supplemental Disclosures

Cash Flow Information


	Year Ended December 31,
	2022		2021		2020
Cash paid during the period for:
Income tax, net of refunds	$	758	$	96	$	59
Interest	$	3,520	$	49,283	$	27,286

Reverse Recapitalization (Tables)

12 Months Ended

Dec. 31, 2022

Reverse Recapitalization [Abstract]

Schedule Of Reverse Recapitalization


Company stockholders			Shares
Class A stockholders immediately prior to merger			17,215,336
Series A preferred stockholders			7,968,316
Series B preferred stockholders			4,597,928
Series B-1 preferred stockholders			2,171,399
2018 convertible noteholders			5,581,416
2019 convertible noteholders			7,846,333
2020 convertible noteholders			4,553,205
Redeemable Series X preferred stockholders			2,140,340
Liberty investors			20,000,000
PIPE investors			5,816,770
Shares issued for Cantor loan repayment			788,021
Shares issued to Sponsor under Forward Purchase Securities Agreement			1,250,000
Issuance of shares for transaction fees			2,058,229
CF V shares			6,837,354
			88,824,647

Revenue from Contract with Customers (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

Information about our revenue by geography is as follows:


	Year Ended December 31,
	2022		2021
Revenue by geography (1)
Asia Pacific	$	1,531	$	3,988
North America	3,438		201
Other	1,043		58
Total revenue	$	6,012	$	4,247

(1)Revenue by geography is based on the geographical location of the customer.

Schedule of Contract with Customer, Contract Asset, Contract Liability, and Receivable


	December 31,
	2022		2021
Non-current	$	1,000	$	1,000
Current	1,941		935
Total	$	2,941	$	1,935

Schedule of Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction

The following table represents the total transaction price for the remaining performance obligations as of December 31, 2022 related to non-cancellable contracts longer than 12 months in duration that is expected to be recognized over future periods.


	Within 1 Year		Years 1-2		Years 2-3		Thereafter
Remaining performance obligations	$	6,422	$	11,296	$	3,860	$	—

Warrant Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Other Liabilities Disclosure [Abstract]

Schedule of Warrant Liability


	Liberty Warrants and Liberty Advisory Fee Warrant		PIPE Warrant		Columbia Warrant		$8.63 Warrants		Total Warrant Liabilities
As of December 31, 2021	$	—	$	—	$	143,237	$	—	$	143,237
Warrants issued	$	30,853	$	1,312	$	—	$	4,872	$	37,037
Change in fair value of financial instruments	(24,662)		(1,001)		(18,635)		(2,702)		(47,000)
Write-off of deferred costs	—		—		203		—		203
Settlements	—		—		—		(337)		(337)
Reclassification to equity	—		—		(124,805)		—		(124,805)
As of December 31, 2022	$	6,191	$	311	$	—	$	1,833	$	8,335

Earnout Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Earnout Liability [Abstract]

Schedule of Earnout Liability


	Sponsor Earnout		Forfeiture Earnout		Total Earnout Liabilities
As of December 31, 2021	$	—	$	—	$	—
Additions	$	8,022	$	6,135	$	14,157
Change in fair value of financial instruments	(6,669)		(5,130)		(11,799)
Reclassification to equity	—		(1,005)		(1,005)
As of December 31, 2022	$	1,353	$	—	$	1,353

Schedule of Assumptions used in the Valuation

Assumptions used in the valuation are as follows:


	January 25,		December 31,
	2022		2022
Expected term (in years)	5.00		4.07
Dividend yield (%)	—		—
Expected volatility	30	%	50.4	%
Risk-free interest rate	1.6	%	4.1	%
Expected number of shares	1,842,759		1,775,962

The following table lists the inputs used under the Black-Scholes model for stock-option awards during the years ended December 31, 2022, 2021, and 2020, respectively:


	Year Ended December 31,
	2022			2021		2020
Weighted-average fair value of options at the measurement date (grant date)	$	—		$	23.36	$	6.31
Dividend yield (%)	—			—		—
Expected volatility (%)	—		%	61 - 72		59 - 61
Risk-free interest rate (%)	—		%	0.5 - 1.4		0.4 - 0.5
Weighted average share price	$	—		$	6.79	$	2.75

Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Summary of Property and Equipment

Property and equipment, net consists of the following:


	Estimated Useful Life (in years)	December 31,
		2022		2021
Satellites in orbit	3	$	54,370	$	43,716
Satellites under construction	Not applicable	22,194		10,558
Leasehold improvements	5-10	6,433		769
Other property and equipment	3-10	4,146		2,138
Total property and equipment		87,143		57,181
Less: Accumulated depreciation		(39,162)		(24,651)
Property and equipment, net		$	47,981	$	32,530

Information related to our property and equipment and operating lease ROU assets by geography is as follows:


	December 31,
	2022		2021
Uruguay	$	43,134	$	33,208
Argentina	1,346		1,250
Spain	729		791
Netherlands	9,471		—
Other countries	1,472		236
Total (1) (2) (3)	$	56,152	$	35,485

(1)Non-current assets include property and equipment, net and operating lease right-of-use assets.

(2)The presentation in the table above is based on the geographic location of the entity that holds the assets.

(3)We do not have any non-current assets in the country of incorporation of the holding company.

Additional Financial Statement Information (Tables)

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Prepaid and Other Current Assets

Prepaid Expenses and Other Current Assets


	December 31,
	2022		2021
Prepaid expenses and other current assets
Prepaid expenses	$	1,767	$	1,153
Advances to suppliers	588		829
Other current assets	843		713
Total	$	3,198	$	2,695

Schedule of Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities


	December 31,
	2022		2021
Accrued expenses and other liabilities
Accrued professional fees related to Merger(1)	$	—	$	16,263
Provisions	71		2,934
Payroll and benefits payable	3,289		2,545
Other taxes payable	3,128		2,045
Other	451		2,200
Total	$	6,939	$	25,987

Total current	$	6,417	$	23,435
Total non-current	$	522	$	2,552

(1)Refer to Note 4 (Reverse Recapitalization) for further details on the Merger.

Schedule of Finance Costs, Net and Other Financial Income (Expense)

Finance Costs, Net


	Year Ended December 31,
	2022		2021		2020
Finance costs, net
Interest expense	$	(1,596)	$	(8,729)	$	(43)
Redeemable Series X preferred stock dividends	(97)		(974)		—
Other finance costs	(123)		(71)		—
Interest income	1,164		36		78
Total	$	(652)	$	(9,738)	$	35

Income Tax (Tables)

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

Our provision for (benefit from) income tax for the years ended December 31, 2022, 2021 and 2020 is as follows:


	Year Ended December 31,
	2022		2021		2020
Current	$	2,972	$	1,387	$	186
Deferred	1,601		(1,619)		(38)
Total provision for (benefit from) income tax	$	4,573	$	(232)	$	148

Schedule of Unrecognized Tax Benefits Roll Forward


	Year Ended December 31,
	2022
Balance at January 1	$	—
Increases (decreases) in tax positions related to the current period	—
Increases (decreases) in tax positions related to prior periods	3,889
Increases (decreases) related to prior year tax positions as a result of lapse of statute	—
Balance at December 31	$	3,889

Schedule of Effective Income Tax Rate Reconciliation


	Year Ended December 31,
	2022		2021		2020
Loss before income tax	$	(32,068)	$	(96,537)	$	(21,381)

Provision for (benefit from) income tax at weighted-average statutory rates	—		—		—
U.S. state and local income tax, net of federal benefit	(3)		5		(4)
U.S. foreign-derived intangible income deduction	(141)		(200)		—
Argentina Tax Inflation Adjustment	239		(381)		(198)
Change in valuation allowances	4,283		3,648		1,198
Uncertain tax positions	2,293		—		—
Change in carryforward attributes	(1,740)		—		—
Effect of rates different than statutory	(423)		(3,300)		(828)
Tax credits	(112)		—		—
Other	177		(4)		(20)
Total	$	4,573	$	(232)	$	148

Schedule of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities as of December 31, 2022 and 2021 consisted of the following:


	December 31,
	2022		2021
Deferred income tax assets:
Stock-based compensation	$	3,023	$	2,053
Bad debt expense	415		407
Deferred financing costs	806		—
Other	193		419
Net operating loss carryforwards	1,365		6,245
Total deferred income tax assets	5,802		9,124
Valuation allowance	(5,802)		(7,484)
Total deferred income tax assets (liabilities), net	$	—	$	1,640

Summary of Tax Credit Carryforwards

Our tax attributes are subject to limitations on utilization due to historic ownership changes and may be subject to future limitations upon subsequent change of control, as defined by the Internal Revenue Code Sections 382 and 383.


Net Operating Loss	Expiration	Gross Amount Carried Forward		Net Amount Recognized as of December 31, 2022
Argentina	December 31, 2023 - December 31, 2027	$	7,864	$	—
Netherlands	Indefinite	2,856		—
China	December 31, 2026 - December 31, 2027	2,258		—
United States	Indefinite	280		—
Uruguay	December 31, 2026 - December 31, 2027	19		—

Stockholder's Equity (Deficit) (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of Authorized and Issued Preferred Stock

Prior to the Merger, our authorized and issued preferred stock consisted of the following:


	Authorized Shares (prior to Merger)	Issued and Outstanding Shares (as of December 31, 2021)
Series A preferred stock	4,723,330	2,547,330
Series B preferred stock	3,117,915	1,392,131
Series B-1 preferred stock	899,153	672,524
Total preferred stock	8,740,398	4,611,985

- Definition

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Stock-based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Share-Based Payment Arrangement, Option, Activity

A summary of stock option activity for the year ended December 31, 2022 is as follows:


	Number of Options	Weighted-Average Exercise Price	Weighted-Average Remaining Contractual Term (years)	Intrinsic Value (in thousands)
Balance as of December 31, 2021	6,864,563	$2.05	2.36
Granted	—	—
Forfeited	(574,299)	4.56
Exercised	(102,825)	1.12
Expired	(120,126)	2.60
Outstanding at December 31, 2022	6,067,313	$1.83	2.07	$	10,818
Exercisable at December 31, 2022	4,449,152	$1.31	1.92	$	8,832

Schedule of Assumptions used in the Valuation

Assumptions used in the valuation are as follows:


	January 25,		December 31,
	2022		2022
Expected term (in years)	5.00		4.07
Dividend yield (%)	—		—
Expected volatility	30	%	50.4	%
Risk-free interest rate	1.6	%	4.1	%
Expected number of shares	1,842,759		1,775,962

The following table lists the inputs used under the Black-Scholes model for stock-option awards during the years ended December 31, 2022, 2021, and 2020, respectively:


	Year Ended December 31,
	2022			2021		2020
Weighted-average fair value of options at the measurement date (grant date)	$	—		$	23.36	$	6.31
Dividend yield (%)	—			—		—
Expected volatility (%)	—		%	61 - 72		59 - 61
Risk-free interest rate (%)	—		%	0.5 - 1.4		0.4 - 0.5
Weighted average share price	$	—		$	6.79	$	2.75

Share-Based Payment Arrangement, Restricted Stock Unit, Activity

A summary of RSU activity for the year ended December 31, 2022 is as follows:


	Number of RSUs	Intrinsic Value (in thousands)
Outstanding unvested RSUs at December 31, 2021	—
Granted during the year	1,640,496
Forfeited during the year	(60,823)
Vested during the year	(120,393)
Expired during the year	—
Outstanding unvested RSUs at December 31, 2022	1,459,280	$1,940

Share-Based Payment Arrangement, Expensed and Capitalized, Amount


	Year Ended December 31,
	2022		2021		2020
General and administrative expenses	$	2,406	$	5,274	$	1,235
Research and development	3,631		1,968		382
Other operating expenses	2,331		3,639		115
Total	$	8,368	$	10,881	$	1,732

Net Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

Basic and diluted net loss per share attributable to common stockholders is calculated as follows:


	Year Ended December 31,
	2022		2021		2020
Net loss attributable to common stockholders	$	(36,641)	$	(96,305)	$	(21,529)
Basic weighted-average common shares outstanding (1)	83,188,276		16,655,634		16,029,826
Basic loss per share for the period attributable to common stockholders	$	(0.44)	$	(5.78)	$	(1.34)
Effect of dilutive securities:
Adjustment to numerator - Change in fair value of Columbia Warrant liability	$	(18,635)	$	—	$	—
Dilutive numerator	$	(55,276)	$	(96,305)	$	(21,529)
Columbia Warrant	609,873		—		—
Diluted weighted-average common shares outstanding	83,798,149		16,655,634		16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(0.66)	$	(5.78)	$	(1.34)

1 After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Schedule of diluted shares outstanding because the effect would have been anti-dilutive

Additionally, the following securities were not included in the computation of diluted shares outstanding because the effect would have been anti-dilutive:


	Year Ended December 31,
	2022	2021	2020
Warrants	49,184,868	15,931,360	—
Sponsor earnout shares	1,775,962	—	—
Stock options	6,067,313	6,864,563	4,694,314
Restricted stock units	1,459,280	—	—
Redeemable convertible preferred stock	—	6,645,215	8,740,398
Total	58,487,423	29,441,138	13,434,712

Fair Value Measurements and Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities at Fair Value

The following tables provide the fair value measurement hierarchy of our assets and liabilities:


As of December 31, 2022	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
$8.63 Warrants liability	$	1,833	$	—	$	—
PIPE Warrant liability	—		—		311
Liberty Warrants and Liberty Advisory Fee Warrant liability	—		—		6,191
Total Warrant Liabilities	$	1,833	$	—	$	6,502
Sponsor Earnout liability	$	—	$	—	$	1,353


As of December 31, 2021	Fair value measurement using
Financial instruments	Quoted prices in active markets (Level 1)		Significant observable inputs (Level 2)		Significant unobservable inputs (Level 3)
Liabilities measured at fair value
Cantor Loan	$	—	$	—	$	7,522
Columbia Warrant liability	—		—		143,237
Liabilities for which fair values are disclosed
Notes	$	—	$	180,356	$	—
Promissory notes	—		40,925		—

Summary of Changes in the Fair Value of Level 3 Liabilities

Changes in the fair value of Level 3 liabilities during the years ended December 31, 2022 and 2021 were as follows:


	Liberty Warrants and Liberty Advisory Fee Warrant		PIPE Warrant		Columbia Warrant		Sponsor Earnout		Forfeiture Earnout		Cantor Loan
At January 1, 2021	$	—	$	—	$	—	$	—	$	—	$	—
Issues	—		—		161,432		—		—		7,513
Remeasurement (gain)/loss(1)	—		—		(17,992)		—		—		9
Amortization of deferred costs	—		—		(203)		—		—		—
At December 31, 2021	—		—		143,237		—		—		7,522
Issues	30,853		1,312		—		8,022		6,135		—
Remeasurement (gain)/loss(1)	(24,662)		(1,001)		(18,635)		(6,669)		(5,130)		488
Write-off of deferred costs	—		—		203		—		—		—
Settlements (2)	—		—		(124,805)		—		(1,005)		(8,010)
At December 31, 2022	$	6,191	$	311	$	—	$	1,353	$	—	$	—

(1)Recognized in the Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2022 and 2021, respectively.

(2)These liabilities were settled in connection with the Merger. See Note 4 (Recapitalization Transaction).

Related Parties (Tables)

12 Months Ended

Dec. 31, 2022

Schedule of Notes Debt Balances and Associated Finance Cost from Related Parties

The following table provides the balances owed and associated finance costs as follows:


	December 31,
	2022		2021		2020
Convertible notes debt from related parties
Amounts owed to related parties	$	—	$	13,028	$	—
Interest expense	$	554	$	620	$	591

Debt (Tables)

12 Months Ended

Dec. 31, 2022

Debt Disclosure [Abstract]

Schedule of Debt

There was no debt as of December 31, 2022. Debt as of December 31, 2021 is as follows:


	December 31, 2021
2018 Convertible Notes	$	19,862
2019 Convertible Notes	27,498
2020 Convertible Notes	15,294
Cantor Loan	7,522
Columbia Loan	38,297
Total debt	108,473
Less deferred financing costs	—
Total debt less deferred financing fees	108,473
Less: Current portion	—
Total non-current debt, net of deferred financing fees	$	108,473

Leases (Tables)

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Schedule of Change in Right-of-Use Assets

Changes in our operating lease ROU assets carrying amounts were as follows:


	December 31,
	2022		2021
Balance as of beginning of period	$	2,955	$	1,403
Lease expense	(1,701)		(494)
Foreign exchange differences	115		(48)
Additions	7,171		2,119
Disposals	(322)		—
Transfers	(47)		(25)
Balance as of end of period	$	8,171	$	2,955

Schedule of Change in Lease Liabilities

Changes in our operating lease liabilities carrying amounts were as follows:


	December 31,
	2022		2021
Balance as of beginning of period	$	3,068	$	1,415
Additions to operating lease liabilities	7,171		2,119
Lease expense	314		54
Foreign exchange differences	(293)		(48)
Disposals	(329)		—
Payments	(1,692)		(472)
Balance as of end of period	$	8,239	$	3,068

Total current	$	2,176	$	985
Total non-current	6,063		2,083

Schedule of Lease, Cost

We recognized in the Consolidated Statements of Operations and Comprehensive Loss the following expenses related to our operating leases for the years ended December 31, 2022, 2021 and 2020:


	Year Ended December 31,
	2022		2021		2020
Right-of-use assets	$	1,701	$	494	$	247
Operating lease liabilities	314		54		51
Total lease expense	$	2,015	$	548	$	298

Summary of Operating Lease Liabilities


	Operating leases
Years Ended
2023	$	2,484
2024	2,235
2025	824
2026	603
2027 and thereafter	3,166
Total remaining lease payments	9,312
Less imputed interest	(1,073)
Present value of lease liability	$	8,239

Total current	$	2,176
Total non-current	$	6,063

Adoption of U.S. GAAP (Tables)

12 Months Ended

Dec. 31, 2022

Adoption of U.S. GAAP [Abstract]

Accounting Standards Update and Change in Accounting Principle

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2021:


	Year Ended December 31, 2021
	IFRS		Adjustments/ Reclassifications		Note	U.S. GAAP
Revenue	$	4,247	$	—		$	4,247
Costs and expenses
Cost of sales	1,876		—			1,876
General administrative expenses	36,649		(9)		a, c	36,640
Research and development	9,640		(4)		b	9,636
Depreciation expense	10,825		(97)		b	10,728
Other operating expenses, net	14,002		—			14,002
Total costs and expenses	72,992		(110)			72,882
Operating loss	(68,745)		110			(68,635)
Other income (expense), net
Finance costs, net	(11,769)		2,031		c, d	(9,738)
Change in fair value of financial instruments	(42,102)		60,085		d	17,983
Gain (loss) on extinguishment of debt	3,576		(40,792)		d	(37,216)
Other income (expense), net	1,067		2		c	1,069
Total other income (expense), net	(49,228)		21,326			(27,902)
Loss before income tax	(117,973)		21,436			(96,537)
Income tax	232		—			232
Net loss available to common stockholders	$	(117,741)	$	21,436		$	(96,305)
Other comprehensive loss
Foreign currency translation loss, net of tax	(86)		—			(86)
Comprehensive loss	$	(117,827)	$	21,436		$	(96,391)

Basic loss for the period attributable to common stockholders	$	(7.07)	$	1.29	e	$	(5.78)
Basic weighted-average common shares outstanding	16,655,634		—		e	16,655,634
Diluted loss for the period attributable to common stockholders	$	(7.07)	$	1.29	e	$	(5.78)
Diluted weighted-average common shares outstanding	16,655,634		—		e	16,655,634

Reconciliation of the Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2020:


	Year Ended December 31, 2020
	IFRS		Adjustments/ Reclassifications		Note	U.S. GAAP
Revenue	$	—	$	—		$	—
Costs and expenses
Cost of sales	—		—			—
General administrative expenses	8,127		(124)		a, c	8,003
Research and development	5,878		46		a, b	5,924
Depreciation expense	3,182		(151)		b	3,031
Other operating expenses, net	5,476		(27)		a, b	5,449
Total costs and expenses	22,663		(256)			22,407
Operating loss	(22,663)		256			(22,407)
Other income (expense), net
Finance costs, net	(22)		57		c, d	35
Change in fair value of financial instruments	(84,224)		93,861		d	9,637
Gain (loss) on extinguishment of debt	(7,466)		(1,774)		d	(9,240)
Other income (expense), net	597		(3)		c	594
Total other income (expense), net	(91,115)		92,141			1,026
Loss before income tax	(113,778)		92,397			(21,381)
Income tax	(148)		—			(148)
Net loss available to common stockholders	$	(113,926)	$	92,397		$	(21,529)
Other comprehensive loss
Foreign currency translation loss, net of tax	—		—			—
Comprehensive loss	$	(113,926)	$	92,397		$	(21,529)

Basic loss for the period attributable to common stockholders	$	(7.11)	$	5.76	e	$	(1.34)
Basic weighted-average common shares outstanding	16,029,826		—		e	16,029,826
Diluted loss for the period attributable to common stockholders	$	(7.11)	$	5.76	e	$	(1.34)
Diluted weighted-average common shares outstanding	16,029,826		—		e	16,029,826

Reconciliation of the Consolidated Balance Sheet as of December 31, 2021:


	IFRS		Adjustments / Reclassifications		Note	U.S. GAAP
ASSETS
Current assets
Cash and cash equivalents	$	8,533	$	—		$	8,533
Accounts receivable	1,196		—			1,196
Prepaid expenses and other current assets	2,695		—			2,695
Total current assets	12,424		—			12,424
Property and equipment, net	33,586		(1,056)		b	32,530
Operating lease right-of-use assets	2,663		292		c	2,955
Deferred income tax assets	1,640		—			1,640
Other non-current assets	369		—			369
Total assets	$	50,682	$	(764)		$	49,918
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable	$	6,650	$	—		$	6,650
Debt	246,189		(137,716)		d	108,473
Warrant liabilities	—		143,237		d	143,237
Operating lease liabilities	891		94		c	985
Contract liabilities	935		—			935
Accrued expenses and other liabilities	23,435		—			23,435
Total current liabilities	278,100		5,615			283,715
Operating lease liabilities	1,908		175		c	2,083
Contract liabilities	1,000		—			1,000
Other non-current liabilities	2,552		—			2,552
Total liabilities	283,560		5,790			289,350
Redeemable preferred stock	—		21,306		d	21,306
Stockholders' equity (deficit)
Treasury stock	(170,949)		—			(170,949)
Additional paid-in capital	235,909		(139,438)		a, d	96,471
Accumulated other comprehensive loss	(86)		—			(86)
Accumulated deficit	(297,752)		111,578			(186,174)
Total stockholders’ equity (deficit)	(232,878)		(27,860)			(260,738)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	50,682	$	(764)		$	49,918

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
General and administrative expenses	$	(80)	$	(136)
Research and development	—		(89)
Other operating expenses	—		(27)
Increase (decrease) to loss before income tax	$	(80)	$	(252)


(Consolidated Balance Sheet)	December 31, 2021
Additional paid-in-capital	$	542
Adjustment to accumulated deficit	(542)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	—

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
Research and development	$	(4)	$	135
Depreciation expense	(97)		(151)
Other operating expenses	—		—
Increase (decrease) to loss before income tax	$	(101)	$	(16)


(Consolidated Balance Sheet)	December 31, 2021
Property and equipment, net	$	(1,056)
Total assets	$	(1,056)
Adjustment to accumulated deficit	$	(1,056)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	(1,056)

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statement of Operations and Comprehensive Loss)	2021		2020
General and administrative expenses	$	71	$	12
Less: Finance costs, net	(49)		(57)
Less: Other income, net	(2)		3
Increase (decrease) to loss before income tax	$	20	$	(42)


(Consolidated Balance Sheet)	December 31, 2021
Operating lease right-of-use assets	$	292
Total assets	$	292
Operating lease liabilities	$	94
Non-current operating lease liabilities	175
Adjustment to accumulated deficit	23
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	292

The impact of this change before considering the tax effect is as follows:


	Year Ended December 31,
(Consolidated Statements of Operations and Comprehensive Loss)	2021		2020
Less: Finance costs, net	$	(1,982)	$	—
Less: Change in fair value of financial instruments	(60,085)		(93,861)
Less: Gain (Loss) on extinguishment of debt	40,792		1,774
Increase (decrease) to loss before income tax	$	(21,275)	$	(92,087)


(Consolidated Balance Sheet)	December 31, 2021
Debt	$	(137,716)
Redeemable Series X preferred stock	21,306
Warrant liability	143,237
Additional paid-in capital	(139,980)
Adjustment to accumulated deficit	113,153
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$	—

The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows:


	Year Ended December 31,
	2021		2020
Net loss attributable to common stockholders	$	(96,305)	$	(21,529)
Basic weighted-average common shares outstanding (1)	16,655,634		16,029,826
Basic loss per share for the period attributable to common stockholders	$	(5.78)	$	(1.34)

Dilutive numerator	$	(96,305)	$	(21,529)
Diluted weighted-average common shares outstanding	16,655,634		16,029,826
Diluted loss per share for the period attributable to common stockholders	$	(5.78)	$	(1.34)

(1) After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).

Nature of the Business and Basis of Presentation - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments \| segment	1
Accumulated deficit	$ (222,815)	$ (186,174)
Net cash used in operating activities	(68,462)	(28,439)	$ (11,174)
Cash and cash equivalents	$ 76,528	$ 8,533

Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Foreign currency transaction gains	$ 1,576	$ 1,022	$ 594

Summary of Significant Accounting Policies - Schedule of Allowance for Credit Loss (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for doubtful accounts, beginning balance	$ (1,794)	$ 0
Bad debt expense	1,736	1,794	$ 0
Write-offs	0	0
Foreign exchange and other	(293)	0
Allowance for doubtful accounts, ending balance	$ (3,237)	$ (1,794)	$ 0

Summary of Significant Accounting Policies - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Cash and cash equivalents	$ 76,528	$ 8,533
Restricted cash	126	0
Restricted cash included in Other non-current assets	1,138	0
Total	$ 77,792	$ 8,533	$ 17,267	$ 24,557

Summary of Significant Accounting Policies - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Income tax, net of refunds	$ 758	$ 96	$ 59
Interest	$ 3,520	$ 49,283	$ 27,286

Reverse Recapitalization - Narrative (Details) $ / shares in Units, $ in Thousands				12 Months Ended
	Feb. 10, 2022 USD ($) anniversary	Jan. 25, 2022 USD ($) $ / shares shares	Jan. 18, 2022 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($) shares	Jul. 31, 2021 $ / shares	Dec. 31, 2019 shares
Schedule of Reverse Recapitalization [Line Items]
Proceeds from reverse recapitalization \| $				$ 167,504	$ 0	$ 0
Long-term debt \| $					$ 108,473
Redeemable preferred shares outstanding (in shares)				0	2,033,230	0		0
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)				2,033,230
Exchange ratio				3.3028	3.3028	3.3028
Cantor Loan \| Cantor Loan
Schedule of Reverse Recapitalization [Line Items]
Long-term debt \| $					$ 7,522
CFAC Holdings V, LLC
Schedule of Reverse Recapitalization [Line Items]
Proceeds from issuance or sale of equity \| $		$ 10,000
Cantor Fitzgerald Securities \| Cantor Loan \| Cantor Loan
Schedule of Reverse Recapitalization [Line Items]
Long-term debt \| $					$ 7,500
CF V shares
Schedule of Reverse Recapitalization [Line Items]
Proceeds from issuance or sale of equity \| $			$ 150,000
Common stock
Schedule of Reverse Recapitalization [Line Items]
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)				2,140,340
Common stock \| Cantor Loan
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, shares, conversion of preferred stock (in shares)				788,021
PIPE Warrant \| Common stock
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, shares, conversion of preferred stock (in shares)				6,108,332
Shares issued to Sponsor under Forward Purchase Securities Agreement \| Common stock
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, shares, conversion of preferred stock (in shares)		1,250,000
Liberty Subscription Agreement \| Common stock
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, shares, conversion of preferred stock (in shares)				20,619,835
Liberty Subscription Agreement - $10 \| CF V shares
Schedule of Reverse Recapitalization [Line Items]
Warrant price (in dollars per share) \| $ / shares			$ 10.00
Liberty Subscription Agreement - $15 \| CF V shares
Schedule of Reverse Recapitalization [Line Items]
Warrant price (in dollars per share) \| $ / shares			$ 15.00
Liberty Warrants \| Liberty Manager
Schedule of Reverse Recapitalization [Line Items]
Warrant price (in dollars per share) \| $ / shares							$ 10.00
Class of warrant or right, advisory fee \| $	$ 1,250			$ 7,500
Class of warrant or right, anniversary period	18 months
Number of successive anniversaries that advisory fee will be paid \| anniversary	5
Class A ordinary shares
Schedule of Reverse Recapitalization [Line Items]
Sale of stock, number of shares issued in transaction (in shares)		5,816,770
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)				2,140,340
Class A ordinary shares \| Cantor Loan
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, shares, conversion of preferred stock (in shares)				788,021
Class A ordinary shares \| CF V shares \| Private Placement
Schedule of Reverse Recapitalization [Line Items]
Sale of stock, number of shares issued in transaction (in shares)			20,000,000
Class A ordinary shares \| CF V shares \| Transaction Fee Payment
Schedule of Reverse Recapitalization [Line Items]
Sale of stock, number of shares issued in transaction (in shares)			2,058,229
Sale of stock, consideration received on transaction \| $			$ 5,000
Class A ordinary shares \| PIPE Warrant
Schedule of Reverse Recapitalization [Line Items]
Number of securities called by warrants or rights (in shares)		2,500,000
Warrant price (in dollars per share) \| $ / shares		$ 20.00
Proceeds from issuance or sale of equity \| $		$ 58,200
Class A ordinary shares \| Shares issued to Sponsor under Forward Purchase Securities Agreement \| CFAC Holdings V, LLC
Schedule of Reverse Recapitalization [Line Items]
Number of securities called by warrants or rights (in shares)		333,333
Class A ordinary shares \| Shares issued to Sponsor under Forward Purchase Securities Agreement \| Common stock
Schedule of Reverse Recapitalization [Line Items]
Warrant price (in dollars per share) \| $ / shares		$ 11.50
Class A ordinary shares \| Liberty Subscription Agreement - $10 \| CF V shares
Schedule of Reverse Recapitalization [Line Items]
Number of securities called by warrants or rights (in shares)			5,000,000
Class A ordinary shares \| Liberty Subscription Agreement - $15 \| CF V shares
Schedule of Reverse Recapitalization [Line Items]
Number of securities called by warrants or rights (in shares)			15,000,000
Class A ordinary shares \| Liberty Warrants \| Liberty Manager
Schedule of Reverse Recapitalization [Line Items]
Number of securities called by warrants or rights (in shares)			2,500,000
Redeemable Series X preferred stockholders
Schedule of Reverse Recapitalization [Line Items]
Preferred stock dividends \| $		$ 21,400

Reverse Recapitalization - Schedule of Reverse Recapitalization (Details) - shares	Jan. 25, 2022	Jan. 24, 2022
Schedule of Reverse Recapitalization [Line Items]
Shares outstanding (in shares)	88,824,647	17,215,336
Issuance of shares for transaction fees (in shares)	2,058,229
Series A preferred stockholders
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	7,968,316
Series B preferred stockholders
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	4,597,928
Series B-1 preferred stockholders
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	2,171,399
2018 Convertible Notes
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, conversion of convertible securities (in shares)	5,581,416
2019 Convertible Notes
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, conversion of convertible securities (in shares)	7,846,333
2020 Convertible Notes
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, conversion of convertible securities (in shares)	4,553,205
Redeemable Series X preferred stockholders
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	2,140,340
Liberty investors
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	20,000,000
PIPE investors
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	5,816,770
Cantor Loan
Schedule of Reverse Recapitalization [Line Items]
Stock issued during period, shares, repayment of loan (in shares)	788,021
CF V shares
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	6,837,354
Shares issued to Sponsor under Forward Purchase Securities Agreement
Schedule of Reverse Recapitalization [Line Items]
Stock issued (in shares)	1,250,000

Revenue from Contract with Customers - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 6,012	$ 4,247	$ 0
Contract with customer, liability, revenue recognized	900	500
Two Customers
Disaggregation of Revenue [Line Items]
Revenue	4,800
One Customer
Disaggregation of Revenue [Line Items]
Revenue		3,900
Transferred over Time
Disaggregation of Revenue [Line Items]
Revenue	1,600	3,800
Transferred at Point in Time
Disaggregation of Revenue [Line Items]
Revenue	$ 4,400	$ 400

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

Revenue from Contract with Customers - Revenue by Geography (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Total revenue	$ 6,012	$ 4,247	$ 0
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	1,531	3,988
North America
Disaggregation of Revenue [Line Items]
Total revenue	3,438	201
Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,043	$ 58

- Definition

+ References

+ Details

Revenue from Contract with Customers - Schedule of Contract Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Non-current	$ 1,000	$ 1,000
Current	1,941	935
Total	$ 2,941	$ 1,935

Revenue from Contract with Customers - Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 6,422
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 11,296
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 3,860
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 0
Revenue, remaining performance obligation, expected timing of satisfaction, period

Warrant Liabilities - Schedule of Warrants (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Warrant Liability [Roll Forward]
As of December 31, 2021	$ 143,237
Warrants issued	37,037
Change in fair value of financial instruments	(47,000)
Write-off of deferred costs	203
Settlements	(337)
Reclassification to equity	(124,805)
As of December 31, 2022	8,335
Liberty Warrants and Liberty Advisory Fee Warrant
Warrant Liability [Roll Forward]
As of December 31, 2021	0
Warrants issued	30,853
Change in fair value of financial instruments	(24,662)
Write-off of deferred costs	0
Settlements	0
Reclassification to equity	0
As of December 31, 2022	6,191
PIPE Warrant
Warrant Liability [Roll Forward]
As of December 31, 2021	0
Warrants issued	1,312
Change in fair value of financial instruments	(1,001)
Write-off of deferred costs	0
Settlements	0
Reclassification to equity	0
As of December 31, 2022	311
Columbia Warrant
Warrant Liability [Roll Forward]
As of December 31, 2021	143,237
Warrants issued	0
Change in fair value of financial instruments	(18,635)
Write-off of deferred costs	203
Settlements	0
Reclassification to equity	(124,805)
As of December 31, 2022	0
$8.63 Warrants
Warrant Liability [Roll Forward]
As of December 31, 2021	0
Warrants issued	4,872
Change in fair value of financial instruments	(2,702)
Write-off of deferred costs	0
Settlements	(337)
Reclassification to equity	0
As of December 31, 2022	$ 1,833

Warrant Liabilities - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 25, 2022	Jan. 24, 2022	Jan. 22, 2022	Jan. 18, 2022	Dec. 31, 2021	Mar. 31, 2021	Mar. 08, 2021
Derivative [Line Items]
Warrant liability	$ 8,335					$ 143,237
Gain from remeasurement of warrants	47,000
Reclassification to equity	124,805
Liberty Warrants and Liberty Advisory Fee Warrant
Derivative [Line Items]
Warrant liability	6,191				$ 30,900	0
Gain from remeasurement of warrants	24,662
Reclassification to equity	0
PIPE Warrant
Derivative [Line Items]
Warrant liability	311			$ 1,300		0
Gain from remeasurement of warrants	1,001
Reclassification to equity	0
Columbia Warrant
Derivative [Line Items]
Warrant liability	0					143,237		$ 161,200
Warrant price (in dollars per share)							$ 2.51635975
Warrants							$ 40,100
Warrants and rights outstanding, term							25 years
Gain from remeasurement of warrants	18,635
Reclassification to equity	124,805
Columbia Warrant \| Common stock
Derivative [Line Items]
Number of securities called by warrants or rights (in shares)							15,931,360
$8.63 Warrants
Derivative [Line Items]
Warrant liability	$ 1,833					$ 0
Warrant price (in dollars per share)	$ 8.63	$ 8.63	$ 11.50
Gain from remeasurement of warrants	$ 2,702
Reclassification to equity	$ 0
Warrant redemption (in dollars per share)		$ 13.50	$ 18.00
CF V shares \| $8.63 Warrants
Derivative [Line Items]
Warrants and rights outstanding, term		5 years
Class of warrant or right, exercisable period after closing date		30 days
Issuance of common stock upon exercise of common stock warrants (in shares)	(613,111)
CF V shares \| SPAC Public Warrants
Derivative [Line Items]
Warrants issued (in shares)		8,333,333
CF V shares \| SPAC Private Placement Warrants
Derivative [Line Items]
Warrants issued (in shares)		200,000
CF V shares \| Shares issued to Sponsor under Forward Purchase Securities Agreement
Derivative [Line Items]
Warrants, unissued (in shares)		333,333

Earnout Liabilities - Earnout Liability (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Earnout Liability [Roll Forward]
As of December 31, 2021	$ 0
Additions	14,157
Change in fair value of financial instruments	(11,799)
Reclassification to equity	(1,005)
As of December 31, 2022	1,353
Sponsor Earnout
Earnout Liability [Roll Forward]
As of December 31, 2021	0
Additions	8,022
Change in fair value of financial instruments	(6,669)
Reclassification to equity	0
As of December 31, 2022	1,353
Forfeiture Earnout
Earnout Liability [Roll Forward]
As of December 31, 2021	0
Additions	6,135
Change in fair value of financial instruments	(5,130)
Reclassification to equity	(1,005)
As of December 31, 2022	$ 0

Earnout Liabilities - Narrative (Details) $ / shares in Units, $ in Millions			12 Months Ended
	Jan. 25, 2022 USD ($) day $ / shares shares	Jan. 18, 2022	Dec. 31, 2022 trading_day day $ / shares shares	Feb. 25, 2022 USD ($)
Earnout Liability [Line Items]
Contingent consideration (in shares) \| shares	1,842,759		1,775,962
Forfeiture Earnout
Earnout Liability [Line Items]
Earnout period		5 years
Earnout period, trigger price (in usd per share)	$ 10.00
Adjustment period	30 days
Earnout liability \| $	$ 6.1			$ 1.0
Forfeiture Earnout \| Trigger Price Two
Earnout Liability [Line Items]
Earnout period, trigger price (in usd per share)	$ 15.00
Contingent consideration, threshold trading days \| day	10
Contingent consideration, threshold non-consecutive trading days	20 days
Forfeiture Earnout \| Class A ordinary shares
Earnout Liability [Line Items]
Contingent consideration, shares in escrow (in shares) \| shares	310,127
CF V shares \| Sponsor Earnout
Earnout Liability [Line Items]
Contingent consideration, threshold trading days \| trading_day			10
Contingent consideration, threshold consecutive trading days \| day			20
CF V shares \| Sponsor Earnout \| Trigger Price One
Earnout Liability [Line Items]
Earnout period, trigger price (in usd per share)			$ 12.50
CF V shares \| Sponsor Earnout \| Trigger Price Two
Earnout Liability [Line Items]
Earnout period, trigger price (in usd per share)			15.00
CF V shares \| Sponsor Earnout \| Trigger Price Three
Earnout Liability [Line Items]
Earnout period, trigger price (in usd per share)			$ 20.00
CF V shares \| Sponsor Earnout \| Class A ordinary shares
Earnout Liability [Line Items]
Earnout period			5 years
Contingent consideration (in shares) \| shares			1,869,000

Earnout Liabilities - Valuation Assumptions (Details) - shares		12 Months Ended
	Jan. 25, 2022	Dec. 31, 2022
Earnout Liability [Abstract]
Expected term (in years)	5 years	4 years 25 days
Dividend yield (%)	0.00%	0.00%
Expected volatility	30.00%	50.40%
Risk-free interest rate	1.60%	4.10%
Expected number of shares (in shares)	1,842,759	1,775,962

Property and Equipment - Summary of Property and Equipment, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 87,143	$ 57,181
Less: Accumulated depreciation	(39,162)	(24,651)
Property and equipment, net	$ 47,981	32,530
Satellites in orbit
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	3 years
Total property and equipment	$ 54,370	43,716
Satellites under construction
Property, Plant and Equipment [Line Items]
Total property and equipment	22,194	10,558
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 6,433	769
Leasehold improvements \| Minimum
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	5 years
Leasehold improvements \| Maximum
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	10 years
Other property and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 4,146	$ 2,138
Other property and equipment \| Minimum
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	3 years
Other property and equipment \| Maximum
Property, Plant and Equipment [Line Items]
Property and equipment, useful life	10 years

Property and Equipment - Geographic Location (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Non-current assets by geography
Property, plant, equipment, and operating lease ROU assets	$ 56,152	$ 35,485
Uruguay
Non-current assets by geography
Property, plant, equipment, and operating lease ROU assets	43,134	33,208
Argentina
Non-current assets by geography
Property, plant, equipment, and operating lease ROU assets	1,346	1,250
Spain
Non-current assets by geography
Property, plant, equipment, and operating lease ROU assets	729	791
Netherlands
Non-current assets by geography
Property, plant, equipment, and operating lease ROU assets	9,471	0
Other countries
Non-current assets by geography
Property, plant, equipment, and operating lease ROU assets	$ 1,472	$ 236

Additional Financial Statement Information - Prepaid and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Prepaid expenses and other current assets
Prepaid expenses	$ 1,767	$ 1,153
Advances to suppliers	588	829
Other current assets	843	713
Total	$ 3,198	$ 2,695

Additional Financial Statement Information - Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accrued expenses and other liabilities
Accrued professional fees related to Merger	$ 0	$ 16,263
Provisions	71	2,934
Payroll and benefits payable	3,289	2,545
Other taxes payable	3,128	2,045
Other	451	2,200
Total	6,939	25,987
Total current	(6,417)	(23,435)
Total non-current	$ 522	$ 2,552

Additional Financial Statement Information - Finance Costs, net and Other Financial Income (Expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Interest expense	$ (1,596)	$ (8,729)	$ (43)
Redeemable Series X preferred stock dividends	(97)	(974)	0
Other finance costs	(123)	(71)	0
Interest income	1,164	36	78
Finance costs, net	$ (652)	$ (9,738)	$ 35

Income Tax - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Current	$ 2,972	$ 1,387	$ 186
Deferred	1,601	(1,619)	(38)
Total provision for (benefit from) income tax	$ 4,573	$ (232)	$ 148

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

Income Tax - Narrative (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Tax Credit Carryforward [Line Items]
Unrecognized tax benefits	$ 3,889,000	$ 0	$ 0
Unrecognized tax benefits, income tax penalties and interest accrued	2,000,000
Operating loss carryforwards	$ 13,300,000	$ 20,900,000

Income Tax - Schedule of Unrecognized Tax Benefits Roll Forward (Details)	12 Months Ended
	Dec. 31, 2022 USD ($)
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning balance	$ 0
Increases (decreases) in tax positions related to the current period	0
Increases (decreases) in tax positions related to prior periods	3,889,000
Increases (decreases) related to prior year tax positions as a result of lapse of statute	0
Ending balance	$ 3,889,000

Income Tax - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Loss before income tax	$ (32,068,000)	$ (96,537,000)	$ (21,381,000)
Provision for (benefit from) income tax at weighted-average statutory rates	0	0	0
U.S. state and local income tax, net of federal benefit	(3,000)	5,000	(4,000)
U.S. foreign-derived intangible income deduction	(141,000)	(200,000)	0
Argentina Tax Inflation Adjustment	239,000	(381,000)	(198,000)
Change in valuation allowances	4,283,000	3,648,000	1,198,000
Uncertain tax positions	2,293,000	0	0
Change in carryforward attributes	(1,740,000)	0	0
Effect of rates different than statutory	(423,000)	(3,300,000)	(828,000)
Tax credits	(112,000)	0	0
Other	177,000	(4,000)	(20,000)
Total provision for (benefit from) income tax	$ 4,573,000	$ (232,000)	$ 148,000

Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Deferred income tax assets:
Stock-based compensation	$ 3,023	$ 2,053
Bad debt expense	415	407
Deferred financing costs	806	0
Other	193	419
Net operating loss carryforwards	1,365	6,245
Total deferred income tax assets	5,802	9,124
Valuation allowance	(5,802)	(7,484)
Total deferred income tax assets (liabilities), net	$ 0	$ 1,640

Income Tax - Summary of Tax Credit Carryforwards (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Argentina
Tax Credit Carryforward [Line Items]
Gross Amount Carried Forward	$ 7,864
Net Amount Recognized as of December 31, 2022	0
Netherlands
Tax Credit Carryforward [Line Items]
Gross Amount Carried Forward	2,856
Net Amount Recognized as of December 31, 2022	0
China
Tax Credit Carryforward [Line Items]
Gross Amount Carried Forward	2,258
Net Amount Recognized as of December 31, 2022	0
United States
Tax Credit Carryforward [Line Items]
Gross Amount Carried Forward	280
Net Amount Recognized as of December 31, 2022	0
Uruguay
Tax Credit Carryforward [Line Items]
Gross Amount Carried Forward	19
Net Amount Recognized as of December 31, 2022	$ 0

Stockholder's Equity (Deficit) - Schedule of Preferred Stock (Details)	Dec. 31, 2021 shares
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)	8,740,398
Preference shares issued (in shares)	4,611,985
Preference shares outstanding (in shares)	4,611,985
Series A preferred stock
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)	4,723,330
Preference shares issued (in shares)	2,547,330
Preference shares outstanding (in shares)	2,547,330
Series B preferred stock
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)	3,117,915
Preference shares issued (in shares)	1,392,131
Preference shares outstanding (in shares)	1,392,131
Series B-1 preferred stock
Class of Stock [Line Items]
Preferred stock, shares authorized (in shares)	899,153
Preference shares issued (in shares)	672,524
Preference shares outstanding (in shares)	672,524

Stockholder's Equity (Deficit) - Narrative (Details)		12 Months Ended
Stockholder's Equity (Deficit) - Narrative (Details)	Apr. 06, 2022 USD ($) shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) shares	Feb. 14, 2022 USD ($)	Jan. 25, 2022 shares	Jan. 24, 2022 shares	Dec. 31, 2019 shares
Noncontrolling Interest [Line Items]
Par value (in dollars per share) \| $ / shares		$ 0.0001	$ 0.0001
Shares outstanding (in shares)						88,824,647	17,215,336
Stock repurchase program, authorized amount \| $					$ 5,000,000
Payments for repurchase of common stock \| $		$ 8,603,000	$ 0	$ 0
Common stock
Noncontrolling Interest [Line Items]
Shares outstanding (in shares)		89,195,437	17,382,854	16,280,360				15,961,703
Shares repurchased (in shares)		516,123
Class A ordinary shares
Noncontrolling Interest [Line Items]
Par value (in dollars per share) \| $ / shares		$ 0.0001
Vote for each share		1
Common stock, shares, issued (in shares)		75,612,795
Shares outstanding (in shares)		75,612,795
Payments for repurchase of common stock \| $		$ 2,700,000
Class A ordinary shares \| Hannover
Noncontrolling Interest [Line Items]
Shares repurchased (in shares)	51,700
Repurchased shares \| $	$ 5,853
Class B ordinary shares
Noncontrolling Interest [Line Items]
Par value (in dollars per share) \| $ / shares		$ 0.0001
Vote for each share		1.472467906
Voting power		20.90%
Conversion period		5 years
Class B ordinary shares \| Chief Executive Officer
Noncontrolling Interest [Line Items]
Shares outstanding (in shares)		13,582,642
Voting power		100.00%
Series A preferred stock \| Hannover
Noncontrolling Interest [Line Items]
Shares repurchased (in shares)	134,735
Series B-1 preferred stock \| Hannover
Noncontrolling Interest [Line Items]
Shares repurchased (in shares)	15,082

Stock-based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Granted during the year (shares)	0
Exercised, intrinsic value	$ 75	$ 23,900	$ 9,700
Share-based payment arrangement, shares withheld for tax withholding obligation (in shares)	17,376
Share-Based Payment Arrangement, Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Award vesting period	4 years
Term of award	10 years
Unrecognized stock-based compensation cost	$ 3,200
Unrecognized stock-based compensation cost, period for recognition	1 year 5 months 1 day
Restricted stock units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based payment arrangement, shares withheld for tax withholding obligation (in shares)	56,649
Weighted-average exercise price of RSUs (in USD per share)	$ 4.38
Unrecognized stock-based compensation cost	$ 5,400
Unrecognized stock-based compensation cost, period for recognition	1 year 5 months 8 days

Stock-based Compensation - Stock Option Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Number of Options
Beginning balance (shares)	6,864,563
Granted during the year (shares)	0
Forfeited during the year (shares)	(574,299)
Exercised during the year (in shares)	(102,825)
Expired during the year (shares)	(120,126)
Ending balance (shares)	6,067,313	6,864,563
Exercisable (in shares)	4,449,152
Weighted-Average Exercise Price
Beginning balance (in usd per share)	$ 2.05
Granted during the year (in usd per share)	0
Forfeited during the year (in usd per share)	4.56
Exercised during the year (in usd per share)	1.12
Expired during the year (in usd per share)	2.60
Ending balance (in usd per share)	1.83	$ 2.05
Exercisable, weighted average exercise price (in usd per share)	$ 1.31
Weighted-Average Remaining Contractual Term (years)
Weighted average remaining contractual life of outstanding options (years)	2 years 25 days	2 years 4 months 9 days
Exercisable, weighted average remaining contractual life of outstanding options (years)	1 year 11 months 1 day
Intrinsic value, outstanding	$ 10,818
Exercisable, intrinsic value	$ 8,832

Stock-based Compensation - Valuation Assumptions (Details) - $ / shares		12 Months Ended
	Jan. 25, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Dividend yield (%)	0.00%	0.00%
Expected volatility	30.00%	50.40%
Risk-free interest rate	1.60%	4.10%
Share-Based Payment Arrangement, Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average fair values at the measurement date (grant date) (in usd per share)		$ 0	$ 23.36	$ 6.31
Dividend yield (%)		0.00%	0.00%	0.00%
Expected volatility		0.00%
Expected volatility (%), minimum			61.00%	59.00%
Expected volatility (%), maximum			72.00%	61.00%
Risk-free interest rate		0.00%
Risk-free interest rate (%), minimum			0.50%	0.40%
Risk-free interest rate (%), maximum			1.40%	0.50%
Share-Based Payment Arrangement, Option \| Weighted Average
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average share price (USD per share)		$ 0	$ 6.79	$ 2.75

Stock-based Compensation - RSU Activity (Details) - Restricted stock units $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) shares
Number of RSUs
Beginning balance (shares)	0
Granted during the year (shares)	1,640,496
Forfeited during the year (shares)	(60,823)
Vested during the year (in shares)	(120,393)
Expired during the year (shares)	0
Ending balance (shares)	1,459,280
Intrinsic Value (in thousands)
Intrinsic value, outstanding \| $	$ 1,940

Stock-based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	$ 8,368	$ 10,881	$ 1,732
General and administrative expenses
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	2,406	5,274	1,235
Research and development
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	3,631	1,968	382
Other operating expenses
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation	$ 2,331	$ 3,639	$ 115

Redeemable Preferred Stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Jan. 25, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Redeemable Preferred Stock [Line Items]
Redeemable preferred shares par value (in dollars per share)		$ 0.0001	$ 0.0001
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)		2,033,230
Reverse recapitalization, conversion price (usd per share)	$ 10.00
Redeemable preferred shares issued (in shares)		0
Redeemable preferred shares outstanding (in shares)		0	2,033,230	0	0
Common stock
Redeemable Preferred Stock [Line Items]
Conversion of redeemable Series X preferred stock and accrued dividends in connection with the Reverse Recapitalization (in shares)		2,140,340
Redeemable Series X preferred stockholders
Redeemable Preferred Stock [Line Items]
Redeemable preferred shares par value (in dollars per share)		$ 0.0001
Dividend rate		7.00%
Conversion of Series X preferred stock in connection with the reverse recapitalization (shares)	2,033,230
Preferred stock dividends	$ 21.4

Net Loss Per Share - Narrative (Details)	12 Months Ended
Net Loss Per Share - Narrative (Details)	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Earnings Per Share [Abstract]
Exchange ratio	3.3028	3.3028	3.3028

Net Loss Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares
Earnings Per Share [Abstract]
Net loss attributable to common stockholders \| $	$ (36,641)	$ (96,305)	$ (21,529)
Basic weighted-average common shares outstanding (in shares) \| shares	83,188,276	16,655,634	16,029,826
Basic loss for the period attributable to common stockholders (in dollars per share) \| $ / shares	$ (0.44)	$ (5.78)	$ (1.34)
Effect of dilutive securities:
Adjustment to numerator - Change in fair value of Columbia Warrant liability (in shares) \| $	$ (18,635)	$ 0	$ 0
Dilutive numerator (in shares) \| $	$ (55,276)	$ (96,305)	$ (21,529)
Columbia warrants (shares) \| shares	609,873	0	0
Diluted weighted-average common shares outstanding (in shares) \| shares	83,798,149	16,655,634	16,029,826
Diluted loss for the period attributable to common stockholders (in dollars per share) \| $ / shares	$ (0.66)	$ (5.78)	$ (1.34)
Exchange ratio	3.3028	3.3028	3.3028

Net Loss Per Share - Schedule of diluted shares outstanding because the effect would have been anti-dilutive (Details)) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	58,487,423	29,441,138	13,434,712
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	49,184,868	15,931,360	0
Sponsor earnout shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,775,962	0	0
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	6,067,313	6,864,563	4,694,314
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	1,459,280	0	0
Redeemable convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total	0	6,645,215	8,740,398

Fair Value Measurements and Financial Instruments - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2022	Jan. 25, 2022	Jan. 24, 2022
Cantor Loan
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Unpaid principal balance	$ 22
$8.63 Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Warrant price (in dollars per share)		$ 8.63	$ 8.63	$ 11.50

Fair Value Measurements and Financial Instruments - Reconciliation of Level 3 Fair Value Measurements of Financial Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Warrant Liability \| Liberty Warrants and Liberty Advisory Fee Warrant
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 0	$ 0
Issues	30,853	0
Remeasurement (gain)/loss	(24,662)	0
Amortization of deferred costs		0
Write-off of deferred costs	0
Settlements	0
Ending balance	6,191	0
Warrant Liability \| PIPE Warrant
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	0
Issues	1,312	0
Remeasurement (gain)/loss	(1,001)	0
Amortization of deferred costs		0
Write-off of deferred costs	0
Settlements	0
Ending balance	311	0
Warrant Liability \| Columbia Warrant
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	143,237	0
Issues	0	161,432
Remeasurement (gain)/loss	(18,635)	(17,992)
Amortization of deferred costs		(203)
Write-off of deferred costs	203
Settlements	(124,805)
Ending balance	0	143,237
Sponsor Earnout
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	0
Issues	8,022	0
Remeasurement (gain)/loss	(6,669)	0
Amortization of deferred costs		0
Write-off of deferred costs	0
Settlements	0
Ending balance	1,353	0
Forfeiture Earnout
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	0	0
Issues	6,135	0
Remeasurement (gain)/loss	(5,130)	0
Amortization of deferred costs		0
Write-off of deferred costs	0
Settlements	(1,005)
Ending balance	0	0
Cantor Loan
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	7,522	0
Issues	0	7,513
Remeasurement (gain)/loss	488	9
Amortization of deferred costs		0
Write-off of deferred costs	0
Settlements	(8,010)
Ending balance	$ 0	$ 7,522

Related Parties - Notes Debt Balances and Associated Finance Cost from Related Parties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Amounts owed to related parties	$ 0	$ 13,028	$ 0
Interest expense	$ 554	$ 620	$ 591

Related Parties - Narrative (Details) - USD ($) $ in Thousands		8 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Acquire equity method investments	$ 3,700		$ 3,653	$ 0	$ 0
Officina Stellare S.p.A.
Schedule of Equity Method Investments [Line Items]
Acquire equity method investments		$ 456

Debt - Schedule of Debt (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Debt Instrument [Line Items]
Total debt	$ 108,473
Less deferred financing costs	0
Total debt less deferred financing fees	108,473
Less: Current portion	0
Total non-current debt, net of deferred financing fees	108,473
Convertible Debt \| 2018 Convertible Notes
Debt Instrument [Line Items]
Total debt	19,862
Convertible Debt \| 2019 Convertible Notes
Debt Instrument [Line Items]
Total debt	27,498
Convertible Debt \| 2020 Convertible Notes
Debt Instrument [Line Items]
Total debt	15,294
Cantor Loan \| Cantor Loan
Debt Instrument [Line Items]
Total debt	7,522
Columbia Loan
Debt Instrument [Line Items]
Total debt	$ 38,297

Debt - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			12 Months Ended
	May 09, 2022	Jan. 25, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Mar. 08, 2021
Debt Instrument [Line Items]
Gain (loss) on extinguishment of debt			$ 0	$ (37,216)	$ (9,240)
Reacquired treasury stock		$ 170,900
Reclassification to equity			124,805
Columbia Warrant
Debt Instrument [Line Items]
Reclassification to equity			$ 124,805
Cantor Loan
Debt Instrument [Line Items]
Debt conversion, converted instrument, shares issued	26,050
VWAP threshold (in dollars per share)		$ 8.00
Debt instrument, converted instrument, additional shares issued		197,005
Columbia Loan
Debt Instrument [Line Items]
Loans payable						$ 40,100
Class A ordinary shares \| Cantor Loan
Debt Instrument [Line Items]
VWAP threshold (in dollars per share)		$ 10.00
Convertible Debt
Debt Instrument [Line Items]
Gain (loss) on extinguishment of debt				$ (37,216)
Convertible Debt \| Class A ordinary shares
Debt Instrument [Line Items]
Debt conversion, converted instrument, shares issued		17,980,954

Leases - Narrative (Details)	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Operating lease, weighted average remaining lease term	5 years 7 months 28 days
Operating lease, weighted average discount rate, percent	4.60%
Minimum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, remaining lease term	2 years
Maximum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, remaining lease term	10 years

Leases - Change in Right-of-Use Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Right-of-Use Assets [Roll Forward]
Beginning balance	$ 2,955	$ 1,403
Lease expense	(1,701)	(494)	$ (247)
Foreign exchange differences	115	(48)
Additions	7,171	2,119
Disposals	(322)	0
Transfers	(47)	(25)
Ending balance	$ 8,171	$ 2,955	$ 1,403

Leases - Change in Operating Lease Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Lease Liability [Roll Forward]
Beginning balance	$ 3,068	$ 1,415
Additions to operating lease liabilities	7,171	2,119
Lease expense	314	54	$ 51
Foreign exchange differences	(293)	(48)
Disposals	(329)	0
Payments	(1,692)	(472)
Ending balance	8,239	3,068	$ 1,415
Total current	2,176	985
Total non-current	$ 6,063	$ 2,083

Leases - Lease Expense (Details) - USD ($) $ in Thousands	12 Months Ended
Leases - Lease Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Right-of-use assets	$ 1,701	$ 494	$ 247
Operating lease liabilities	314	54	51
Total lease expense	$ 2,015	$ 548	$ 298

Leases - Operating Lease Maturity (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2023	$ 2,484
2024	2,235
2025	824
2026	603
2027 and thereafter	3,166
Total remaining lease payments	9,312
Less imputed interest	(1,073)
Present value of lease liability	8,239	$ 3,068	$ 1,415
Total current	2,176	985
Total non-current	$ 6,063	$ 2,083

Adoption of U.S. GAAP - Reconciliation of Condensed Consolidated Statement of Operations and Comprehensive Loss (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue	$ 6,012,000	$ 4,247,000	$ 0
Cost of sales	3,284,000	1,876,000	0
General and administrative expenses	37,191,000	36,640,000	8,003,000
Research and development	13,055,000	9,636,000	5,924,000
Depreciation expense	14,326,000	10,728,000	3,031,000
Other operating expenses, net	29,023,000	14,002,000	5,449,000
Total costs and expenses	96,879,000	72,882,000	22,407,000
Operating loss	(90,867,000)	(68,635,000)	(22,407,000)
Finance costs, net	(652,000)	(9,738,000)	35,000
Change in fair value of financial instruments	58,311,000	17,983,000	9,637,000
Loss on extinguishment of debt	0	(37,216,000)	(9,240,000)
Other income (expense), net	1,140,000	1,069,000	594,000
Total other income (expense), net		(27,902,000)	1,026,000
Loss before income tax	(32,068,000)	(96,537,000)	(21,381,000)
Income tax (expense) benefit	(4,573,000)	232,000	(148,000)
Net loss	(36,641,000)	(96,305,000)	(21,529,000)
Foreign currency translation loss, net of tax	(226,000)	(86,000)	0
Comprehensive loss	$ (36,867,000)	$ (96,391,000)	$ (21,529,000)
Basic loss for the period attributable to common stockholders (in dollars per share)	$ (0.44)	$ (5.78)	$ (1.34)
Weighted average number of ordinary shares (basic) (in shares)	83,188,276	16,655,634	16,029,826
Diluted loss for the period attributable to common stockholders (in dollars per share)	$ (0.66)	$ (5.78)	$ (1.34)
Weighted average number of ordinary shares (diluted) (in shares)	83,798,149	16,655,634	16,029,826
IFRS
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue		$ 4,247,000	$ 0
Cost of sales		1,876,000	0
General and administrative expenses		36,649,000	8,127,000
Research and development		9,640,000	5,878,000
Depreciation expense		10,825,000	3,182,000
Other operating expenses, net		14,002,000	5,476,000
Total costs and expenses		72,992,000	22,663,000
Operating loss		(68,745,000)	(22,663,000)
Finance costs, net		(11,769,000)	(22,000)
Change in fair value of financial instruments		(42,102,000)	(84,224,000)
Loss on extinguishment of debt		3,576,000	(7,466,000)
Other income (expense), net		1,067,000	597,000
Total other income (expense), net		(49,228,000)	(91,115,000)
Loss before income tax		(117,973,000)	(113,778,000)
Income tax (expense) benefit		232,000	(148,000)
Net loss		(117,741,000)	(113,926,000)
Foreign currency translation loss, net of tax		(86,000)	0
Comprehensive loss		$ (117,827,000)	$ (113,926,000)
Basic loss for the period attributable to common stockholders (in dollars per share)		$ (7.07)	$ (7.11)
Weighted average number of ordinary shares (basic) (in shares)		16,655,634	16,029,826
Diluted loss for the period attributable to common stockholders (in dollars per share)		$ (7.07)	$ (7.11)
Weighted average number of ordinary shares (diluted) (in shares)		16,655,634	16,029,826
Adjustments/ Reclassifications
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Revenue		$ 0	$ 0
Cost of sales		0	0
General and administrative expenses		(9,000)	(124,000)
Research and development		(4,000)	46,000
Depreciation expense		(97,000)	(151,000)
Other operating expenses, net		0	(27,000)
Total costs and expenses		(110,000)	(256,000)
Operating loss		110,000	256,000
Finance costs, net		2,031,000	57,000
Change in fair value of financial instruments		60,085,000	93,861,000
Loss on extinguishment of debt		(40,792,000)	(1,774,000)
Other income (expense), net		2,000	(3,000)
Total other income (expense), net		21,326,000	92,141,000
Loss before income tax		21,436,000	92,397,000
Income tax (expense) benefit		0	0
Net loss		21,436,000	92,397,000
Foreign currency translation loss, net of tax		0	0
Comprehensive loss		$ 21,436,000	$ 92,397,000
Basic loss for the period attributable to common stockholders (in dollars per share)		$ 1.29	$ 5.76
Weighted average number of ordinary shares (basic) (in shares)		0	0
Diluted loss for the period attributable to common stockholders (in dollars per share)		$ 1.29	$ 5.76
Weighted average number of ordinary shares (diluted) (in shares)		0	0

Adoption of U.S. GAAP - Reconciliation of Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 76,528	$ 8,533
Accounts receivable	1,388	1,196
Prepaid expenses and other current assets	3,198	2,695
Total current assets	81,240	12,424
Property and equipment, net	47,981	32,530
Operating lease right-of-use assets	8,171	2,955	$ 1,403
Deferred income tax assets	0	1,640
Other non-current assets	6,463	369
Total assets	143,855	49,918
Current liabilities
Accounts payable	9,850	6,650
Debt	0	108,473
Warrant liabilities	8,335	143,237
Operating lease liabilities	2,176	985
Contract liabilities	1,941	935
Accrued expenses and other liabilities	6,417	23,435
Total current liabilities	30,072	283,715
Operating lease liabilities	6,063	2,083
Contract liabilities	1,000	1,000
Other non-current liabilities	522	2,552
Total liabilities	37,657	289,350
Redeemable Series X preferred stock	0	21,306	0	$ 0
Stockholders' equity (deficit)
Treasury stock	(8,603)	(170,949)
Additional paid-in capital	337,928	96,471
Accumulated other comprehensive loss	(312)	(86)
Accumulated deficit	(222,815)	(186,174)
Total stockholders’ equity (deficit)	106,198	(260,738)	$ (25,828)	$ (5,449)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$ 143,855	49,918
IFRS
Current assets
Cash and cash equivalents		8,533
Accounts receivable		1,196
Prepaid expenses and other current assets		2,695
Total current assets		12,424
Property and equipment, net		33,586
Operating lease right-of-use assets		2,663
Deferred income tax assets		1,640
Other non-current assets		369
Total assets		50,682
Current liabilities
Accounts payable		6,650
Debt		246,189
Warrant liabilities		0
Operating lease liabilities		891
Contract liabilities		935
Accrued expenses and other liabilities		23,435
Total current liabilities		278,100
Operating lease liabilities		1,908
Contract liabilities		1,000
Other non-current liabilities		2,552
Total liabilities		283,560
Redeemable Series X preferred stock		0
Stockholders' equity (deficit)
Treasury stock		(170,949)
Additional paid-in capital		235,909
Accumulated other comprehensive loss		(86)
Accumulated deficit		(297,752)
Total stockholders’ equity (deficit)		(232,878)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		50,682
Adjustments/ Reclassifications
Current assets
Cash and cash equivalents		0
Accounts receivable		0
Prepaid expenses and other current assets		0
Total current assets		0
Property and equipment, net		(1,056)
Operating lease right-of-use assets		292
Deferred income tax assets		0
Other non-current assets		0
Total assets		(764)
Current liabilities
Accounts payable		0
Debt		(137,716)
Warrant liabilities		143,237
Operating lease liabilities		94
Contract liabilities		0
Accrued expenses and other liabilities		0
Total current liabilities		5,615
Operating lease liabilities		175
Contract liabilities		0
Other non-current liabilities		0
Total liabilities		5,790
Redeemable Series X preferred stock		21,306
Stockholders' equity (deficit)
Treasury stock		0
Additional paid-in capital		(139,438)
Accumulated other comprehensive loss		0
Accumulated deficit		111,578
Total stockholders’ equity (deficit)		(27,860)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		$ (764)

Adoption of U.S. GAAP - Impact of Change Before Considering The Tax Effect from Share-Based Compensation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
Research and development	$ 13,055,000	$ 9,636,000	$ 5,924,000
Other operating expenses	29,023,000	14,002,000	5,449,000
Loss before income tax	(32,068,000)	(96,537,000)	(21,381,000)
(Condensed Consolidated Balance Sheet)
Additional paid-in capital	337,928,000	96,471,000
Adjustment to accumulated deficit	(222,815,000)	(186,174,000)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$ 143,855,000	49,918,000
Adjustments/ Reclassifications
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
Research and development		(4,000)	46,000
Other operating expenses		0	(27,000)
Loss before income tax		21,436,000	92,397,000
(Condensed Consolidated Balance Sheet)
Additional paid-in capital		(139,438,000)
Adjustment to accumulated deficit		111,578,000
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		(764,000)
Adjustments/ Reclassifications \| IFRS Impact on Share-Based Compensation
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
General and administrative expenses		(80,000)	(136,000)
Research and development		0	(89,000)
Other operating expenses		0	(27,000)
Loss before income tax		(80,000)	$ (252,000)
(Condensed Consolidated Balance Sheet)
Additional paid-in capital		542,000
Adjustment to accumulated deficit		(542,000)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		$ 0

Adoption of U.S. GAAP - Impact of Change Before Considering The Tax Effect from Research and Development (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
Research and development	$ 13,055,000	$ 9,636,000	$ 5,924,000
Depreciation expense	14,326,000	10,728,000	3,031,000
Total other income (expense), net		(27,902,000)	1,026,000
Loss before income tax	(32,068,000)	(96,537,000)	(21,381,000)
(Condensed Consolidated Balance Sheet)
Property and equipment, net	47,981,000	32,530,000
Total assets	143,855,000	49,918,000
Adjustment to accumulated deficit	(222,815,000)	(186,174,000)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$ 143,855,000	49,918,000
Adjustments/ Reclassifications
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
Research and development		(4,000)	46,000
Depreciation expense		(97,000)	(151,000)
Total other income (expense), net		21,326,000	92,141,000
Loss before income tax		21,436,000	92,397,000
(Condensed Consolidated Balance Sheet)
Property and equipment, net		(1,056,000)
Total assets		(764,000)
Adjustment to accumulated deficit		111,578,000
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		(764,000)
Adjustments/ Reclassifications \| IFRS Impact on Research and Development
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
Research and development		(4,000)	135,000
Depreciation expense		(97,000)	(151,000)
Total other income (expense), net		0	0
Loss before income tax		(101,000)	$ (16,000)
(Condensed Consolidated Balance Sheet)
Property and equipment, net		(1,056,000)
Total assets		(1,056,000)
Adjustment to accumulated deficit		(1,056,000)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		$ (1,056,000)

Adoption of U.S. GAAP - Impact of Change Before Considering The Tax Effect from Leases (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
General and administrative expenses	$ 37,191,000	$ 36,640,000	$ 8,003,000
Finance costs, net	(652,000)	(9,738,000)	35,000
Other income, net	1,140,000	1,069,000	594,000
Loss before income tax	(32,068,000)	(96,537,000)	(21,381,000)
(Condensed Consolidated Balance Sheet)
Operating lease right-of-use assets	8,171,000	2,955,000	1,403,000
Total assets	143,855,000	49,918,000
Operating lease liabilities	8,239,000	3,068,000	1,415,000
Non-current operating lease liabilities	6,063,000	2,083,000
Adjustment to accumulated deficit	(222,815,000)	(186,174,000)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$ 143,855,000	49,918,000
Adjustments/ Reclassifications
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
General and administrative expenses		(9,000)	(124,000)
Finance costs, net		2,031,000	57,000
Other income, net		2,000	(3,000)
Loss before income tax		21,436,000	92,397,000
(Condensed Consolidated Balance Sheet)
Operating lease right-of-use assets		292,000
Total assets		(764,000)
Non-current operating lease liabilities		175,000
Adjustment to accumulated deficit		111,578,000
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		(764,000)
Adjustments/ Reclassifications \| IFRS Impact on Leases
(Condensed Consolidated Statement of Operations and Comprehensive Loss)
General and administrative expenses		71,000	12,000
Finance costs, net		(49,000)	(57,000)
Other income, net		(2,000)	3,000
Loss before income tax		20,000	$ (42,000)
(Condensed Consolidated Balance Sheet)
Operating lease right-of-use assets		292,000
Total assets		292,000
Operating lease liabilities		94,000
Non-current operating lease liabilities		175,000
Adjustment to accumulated deficit		23,000
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		$ 292,000

Adoption of U.S. GAAP - Impact of Change Before Considering The Tax Effect from Financial Instruments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Finance costs, net	$ (652,000)	$ (9,738,000)	$ 35,000
Change in fair value of financial instruments	58,311,000	17,983,000	9,637,000
Gain (loss) on extinguishment of debt	0	(37,216,000)	(9,240,000)
Loss before income tax	(32,068,000)	(96,537,000)	(21,381,000)
Debt	0	108,473,000
Redeemable Series X preferred stock	0	21,306,000	0	$ 0
Warrant liability	8,335,000	143,237,000
Additional paid-in capital	337,928,000	96,471,000
Adjustment to accumulated deficit	(222,815,000)	(186,174,000)
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)	$ 143,855,000	49,918,000
Adjustments/ Reclassifications
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Finance costs, net		2,031,000	57,000
Change in fair value of financial instruments		60,085,000	93,861,000
Gain (loss) on extinguishment of debt		(40,792,000)	(1,774,000)
Loss before income tax		21,436,000	92,397,000
Debt		(137,716,000)
Redeemable Series X preferred stock		21,306,000
Warrant liability		143,237,000
Additional paid-in capital		(139,438,000)
Adjustment to accumulated deficit		111,578,000
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		(764,000)
Adjustments/ Reclassifications \| IFRS Impact on Financial Instruments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Finance costs, net		(1,982,000)	0
Change in fair value of financial instruments		(60,085,000)	(93,861,000)
Gain (loss) on extinguishment of debt		40,792,000	1,774,000
Loss before income tax		(21,275,000)	$ (92,087,000)
Debt		(137,716,000)
Redeemable Series X preferred stock		21,306,000
Warrant liability		143,237,000
Additional paid-in capital		(139,980,000)
Adjustment to accumulated deficit		113,153,000
Total liabilities, redeemable preferred stock and stockholders' equity (deficit)		$ 0

Adoption of U.S. GAAP - Impact of Change Before Considering The Tax Effect from Earnings Per Share (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net loss \| $	$ (36,641)	$ (96,305)	$ (21,529)
Weighted average number of ordinary shares (basic) (in shares) \| shares	83,188,276	16,655,634	16,029,826
Loss per share basic (in dollars per share)	$ (0.44)	$ (5.78)	$ (1.34)
Weighted average number of ordinary shares (Dilutive) (in shares) \| shares	83,798,149	16,655,634	16,029,826
Diluted loss for the period attributable to common stockholders (in dollars per share)	$ (0.66)	$ (5.78)	$ (1.34)
Exchange ratio	3.3028	3.3028	3.3028
Adjustments/ Reclassifications
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net loss \| $		$ 21,436	$ 92,397
Weighted average number of ordinary shares (basic) (in shares) \| shares		0	0
Loss per share basic (in dollars per share)		$ 1.29	$ 5.76
Diluted loss for the period attributable to common stockholders (in dollars per share)		$ 1.29	$ 5.76
Adjustments/ Reclassifications \| IFRS Impact on Earnings Per Share
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net loss \| $		$ (96,305)	$ (21,529)
Weighted average number of ordinary shares (basic) (in shares) \| shares		16,655,634	16,029,826
Loss per share basic (in dollars per share)		$ (5.78)	$ (1.34)
Loss for the year attributable to Equity holders of the parent (diluted) \| $		$ (96,305)	$ (21,529)
Diluted loss for the period attributable to common stockholders (in dollars per share)		$ (5.78)	$ (1.34)

Equity Method Investment (Details) - USD ($) $ in Thousands		12 Months Ended
Equity Method Investment (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Schedule of Equity Method Investments [Line Items]
Equity method investment, outstanding common shares, percent	5.00%
Equity investment in OS	$ 3,700	$ 3,653	$ 0	$ 0
Conversion period	36 months
Warrants \| OS
Schedule of Equity Method Investments [Line Items]
Warrants issued (in shares)	524,715

Subsequent Events (Details) - Class B ordinary shares	Mar. 08, 2023	Mar. 07, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Vote for each share			1.472467906
Subsequent Event
Subsequent Event [Line Items]
Vote for each share	1.472467906	1.463844005

Fair Value Measurements and Financial Instruments - Fair Value Measurement Hierarchy (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 22, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	$ 8,335		$ 143,237
$8.63 Warrants liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	1,833		0
PIPE Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	311	$ 1,300	0
Quoted prices in active markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	1,833
Sponsor Earnout liability	0
Cantor Loan			0
Quoted prices in active markets (Level 1) \| Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes			0
Quoted prices in active markets (Level 1) \| Promissory notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes			0
Quoted prices in active markets (Level 1) \| $8.63 Warrants liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	1,833
Quoted prices in active markets (Level 1) \| PIPE Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	0
Quoted prices in active markets (Level 1) \| Liberty Warrants and Liberty Advisory Fee Warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	0
Quoted prices in active markets (Level 1) \| Columbia Warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability			0
Significant observable inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	0
Sponsor Earnout liability	0
Cantor Loan			0
Significant observable inputs (Level 2) \| Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes			180,356
Significant observable inputs (Level 2) \| Promissory notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes			40,925
Significant observable inputs (Level 2) \| $8.63 Warrants liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	0
Significant observable inputs (Level 2) \| PIPE Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	0
Significant observable inputs (Level 2) \| Liberty Warrants and Liberty Advisory Fee Warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	0
Significant observable inputs (Level 2) \| Columbia Warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability			0
Significant unobservable inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	6,502
Sponsor Earnout liability	1,353
Cantor Loan			7,522
Significant unobservable inputs (Level 3) \| Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes			0
Significant unobservable inputs (Level 3) \| Promissory notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes			0
Significant unobservable inputs (Level 3) \| $8.63 Warrants liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	0
Significant unobservable inputs (Level 3) \| PIPE Warrant
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	311
Significant unobservable inputs (Level 3) \| Liberty Warrants and Liberty Advisory Fee Warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability	$ 6,191
Significant unobservable inputs (Level 3) \| Columbia Warrant liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrant liability			$ 143,237